血液内科学

318  件  
※ 登録方法の違いにより重複して表示されている場合があります。

  1. Sugimoto Y, Nagaharu K, Ohya E, Ohishi K, Tawara I, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Saito AM, Shimoda K, Kurokawa T, Tomita A, Edahiro Y, Hashimoto Y, Kiyoi H, Akashi K, Matsumura I, Takenaka K, Komatsu N: Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in Japan. International journal of hematology. 2024.12; 120 (6): 684-693. ( PubMed , DOI )

  2. Motomura Y, Yoshifuji K, Tanaka K, Sakashita C, Umezawa Y, Nagao T, Nitta S, Asahina Y, Mori T, Yamamoto M.: Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma J Clin Exp Hematop.. 2024.11;

  3. Shintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, Masamichi Yamamoto, Daiki Karigane, Kohei Shiroshita, Yuriko Sorimachi, Takayuki Morikawa, Shinya Fujita, Kotaro Shide, Miho Haraguchi, Shinpei Tamaki, Takumi Mikawa, Hiroshi Kondoh, Hiroyasu Nakano, Kenta Sumiyama, Go Nagamatsu, Nobuhito Goda, Shinichiro Okamoto, Ayako Nakamura-Ishizu, Kazuya Shimoda, Makoto Suematsu, Toshio Suda, Keiyo Takubo: SDHAF1 confers metabolic resilience to aging hematopoietic stem cells by promoting mitochondrial ATP production. Cell Stem Cell. 2024.08; 31 (8): 1145-1161.e15. ( PubMed , DOI )

  4. Mikita K, Mori T, Komine T, Kobayashi S, Iwata S, Suzuki K, Hasegawa N: Development of a LAMP method with lateral flow DNA chromatography to diagnose toxoplasmosis in immunocompromised patients. Tropical medicine and health. 2024.07; 52 (1): 45. ( PubMed , DOI )

  5. Ohwada C, Sakaida E, Takeda Y, Doki N, Igarashi A, Onizuka M, Toyosaki M, Tanaka M, Tachibana T, Kataoka K, Kato J, Fujisawa S, Kato S, Nakasone H, Naganuma K, Saitoh T, Shono K, Hagihara M, Saito T, Usuki K, Mori T, Nakaseko C, Okamoto S, Kanda Y: Survival impact of response within the first year in a multicenter prospective observational study of chronic GVHD in a Japanese cohort. International journal of hematology. 2024.07; 120 (3): 347-355. ( PubMed , DOI )

  6. Nagaharu K, Ohya E, Edahiro Y, Hashimoto Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Saito AM, Shimoda K, Kurokawa T, Tomita A, Kiyoi H, Akashi K, Matsumura I, Takenaka K, Komatsu N, Ohishi K, Tawara I, Sugimoto Y: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis. Annals of hematology. 2024.07; 103 (9): 3535-3541. ( PubMed , DOI )

  7. Akiyama M, Kanayama M, Umezawa Y, Nagao T, Izumi Y, Yamamoto M, Ohteki T: An early regulatory mechanism of hyperinflammation by restricting monocyte contribution. Frontiers in immunology. 2024.07; 15 1398153. ( PubMed , DOI )

  8. Yoshifuji K, Sadato D, Toya T, Motomura Y, Hirama C, Takase H, Yamamoto K, Harada Y, Mori T, Nagao T: Impact of genetic alterations on central nervous system progression of primary vitreoretinal lymphoma. Haematologica. 2024.06; ( PubMed , DOI )

  9. Umezawa Y, Yoshifuji K, Tanaka K, Nogami A, Nagano K, Tsuji A, Nagao T, Yamamoto M, Kajiwara M, Tohda S, Mori T: Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation. Annals of hematology. 2024.05; 103 (5): 1737-1744. ( PubMed , DOI )

  10. Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, Isoda T, Takagi M, Kajiwara M, Azumi S, Hirabayashi S, Sakamoto K, Kishimoto K, Miyamura T, Umeda K, Hirose A, Keino D, Yanagimachi M, Kanda K, Sakai Y, Ikawa Y, Watanabe K, Tanaka K, Mori T, Ichinohe T, Sakaguchi H, Morio T, Kanegane H: Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024.05; 44 (6): 126. ( PubMed , DOI )

  11. Jonas L Fowler, Sherry Li Zheng, Alana Nguyen, Angela Chen, Xiaochen Xiong, Timothy Chai, Julie Y Chen, Daiki Karigane, Allison M Banuelos, Kouta Niizuma, Kensuke Kayamori, Toshinobu Nishimura, M Kyle Cromer, David Gonzalez-Perez, Charlotte Mason, Daniel Dan Liu, Leyla Yilmaz, Lucile Miquerol, Matthew H Porteus, Vincent C Luca, Ravindra Majeti, Hiromitsu Nakauchi, Kristy Red-Horse, Irving L Weissman, Lay Teng Ang, Kyle M Loh: Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells. Developmental Cell. 2024.05; 59 (9): 1110-1131.e22. ( PubMed , DOI )

  12. Shintaro Watanuki, Hiroshi Kobayashi, Yuki Sugiura, Masamichi Yamamoto, Daiki Karigane, Kohei Shiroshita, Yuriko Sorimachi, Shinya Fujita, Takayuki Morikawa, Shuhei Koide, Motohiko Oshima, Akira Nishiyama, Koichi Murakami, Miho Haraguchi, Shinpei Tamaki, Takehiro Yamamoto, Tomohiro Yabushita, Yosuke Tanaka, Go Nagamatsu, Hiroaki Honda, Shinichiro Okamoto, Nobuhito Goda, Tomohiko Tamura, Ayako Nakamura-Ishizu, Makoto Suematsu, Atsushi Iwama, Toshio Suda, Keiyo Takubo: Context-dependent modification of PFKFB3 in hematopoietic stem cells promotes anaerobic glycolysis and ensures stress hematopoiesis. Elife. 2024.04; 12 ( PubMed , DOI )

  13. Fabian P Suchy, Daiki Karigane, Yusuke Nakauchi, Maimi Higuchi, Jinyu Zhang, Katja Pekrun, Ian Hsu, Amy C Fan, Toshinobu Nishimura, Carsten T Charlesworth, Joydeep Bhadury, Toshiya Nishimura, Adam C Wilkinson, Mark A Kay, Ravindra Majeti, Hiromitsu Nakauchi: Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors. Nature Biotechnology. 2024.04; ( PubMed , DOI )

  14. Toya T, Mizuno K, Sakurai M, Kato J, Mori T, Doki N, Masuda S, Aotsuka N, Tsukamoto S, Sakaida E, Nakajima Y, Fujisawa S, Machida S, Aoyama Y, Yokoyama H, Shono K, Hatta Y, Usuki K, Kataoka K, Kanda Y: Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis. Blood advances. 2024.03; 8 (5): 1084-1093. ( PubMed , DOI )

  15. Kawade G, Kurata M, Matsuki Y, Fukuda S, Onishi I, Kinowaki Y, Watabe S, Ishibashi S, Ikeda M, Yamamoto M, Ohashi K, Kitagawa M, Yamamoto K: Mediation of FSP1 expression via 4-HNE accumulation contributes to acquisition of resistance to apoptosis and ferroptosis in DLBCL. Laboratory investigation; a journal of technical methods and pathology. 2024.02; 102027. ( PubMed , DOI )

  16. Yamamoto R, Hiramoto N, Fujimoto A, Yamazaki H, Mori T, Uchida N, Doki N, Kato J, Nishikubo M, Kako S, Nishida T, Ota S, Onizuka M, Eto T, Onodera K, Ikegame K, Matsuoka KI, Kanda Y, Fukuda T, Atsuta Y, Onishi Y: Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation. Bone marrow transplantation. 2024.02; 59 (5): 688-691. ( PubMed , DOI )

  17. Hikaru Aoki, Yasunari Miyazaki, Tatsuhiko Anzai, Kota Yokoyama, Junichi Tsuchiya, Tsuyoshi Shirai, Sho Shibata, Rie Sakakibara, Takahiro Mitsumura, Takayuki Honda, Haruhiko Furusawa, Tsukasa Okamoto, Tomoya Tateishi, Meiyo Tamaoka, Masahide Yamamoto, Kunihiko Takahashi, Ukihide Tateishi, Tetsuo Yamaguchi: Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on 18F-FDG maximum-intensity projection images. Eur Radiol. 2024.01; 34 (1): 374-383. ( PubMed , DOI )

  18. Noriharu Nakagawa, Ken Ishiyama, Kensuke Usuki, Satoru Takada, Tatsuki Tomikawa, Hiroshi Handa, Yuna Katsuoka, Daiki Hirano, Nobuo Sezaki, Masahiko Sumi, Shin Fujisawa, Yasuhiro Taniguchi, Atsuko Mugitani, Takuro Yoshimura, Eiichi Ohtsuka, Ken Takase, Youko Suehiro, Shuichi Ota, Tomohiro Kajiguchi, Tomoya Maeda, Masahide Yamamoto, Shigeki Ohtake, Akira Katsumi, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki: Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT. Ann Hematol. 2024.01; 103 (1): 307-320. ( PubMed , DOI )

  19. Niklas Landberg, Thomas Köhnke, Yang Feng, Yusuke Nakauchi, Amy C Fan, Miles H Linde, Daiki Karigane, Kelly Lim, Rahul Sinha, Luca Malcovati, Daniel Thomas, Ravindra Majeti: IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation. Blood Cancer Discovery. 2024.01; OF1-OF18. ( PubMed , DOI )

  1. Motomura, Y; Yoshifuji, K; Tachibana, T; Takase, H; Arai, A; Tanaka, K; Okada, K; Nogami, A; Umezawa, Y; Sakashita, C; Yamamoto, M; Mori, T; Nagao, T: Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma BRITISH JOURNAL OF HAEMATOLOGY. 2023.12; ( PubMed , DOI )

  2. Onishi Y, Mori T, Yamazaki H, Hiramoto N, Zaimoku Y, Kanaya M, Matsue K, Onizuka M, Aotsuka N, Uchida N, Onodera K, Kanda J, Nakamae H, Yamamoto R, Kuriyama T, Kimura T, Ichinohe T, Atsuta Y, Adult Aplastic Anemia Working Group of the Japanese Society for Transplantation and Cellular Therapy: Comparison of haploidentical stem cell transplantation with post-transplant cyclophosphamide versus umbilical cord blood transplantation in adult patients with aplastic anemia. Transplantation and cellular therapy. 2023.12; 29 (12): 766.e1-766.e8. ( PubMed , DOI )

  3. Yusuke Nakauchi, Asiri Ediriwickrema, Daniel Martinez-Krams, Feifei Zhao, Athreya Rangavajhula, Daiki Karigane, Ravindra Majeti: Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis. Journal of Visualized Experiments. 2023.11; (201): ( PubMed , DOI )

  4. Shimizu H, Najima Y, Kako S, Tanaka M, Fujiwara SI, Mori T, Usuki K, Gotoh M, Hagihara M, Tsukada N, Oniduka M, Takada S, Sakaida E, Fujisawa S, Onoda M, Aotsuka N, Yano S, Ohashi K, Takahashi S, Okamoto S, Kanda Y, Kanto Study Group for Cell Therapy (KSGCT): Clinical significance of late CMV disease in adult patients who underwent allogeneic stem cell transplant. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023.10; 29 (12): 1103-1108. ( PubMed , DOI )

  5. Kako S, Kimura SI, Wada H, Komiya Y, Nakasone H, Sakurai M, Kato J, Tanaka M, Fujii E, Tachibana T, Yamamoto W, Hagihara M, Watanabe R, Yokota A, Nakano H, Mori T, Nakaseko C, Kanamori H, Okamoto S, Kanda Y: Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study. Leukemia research. 2023.10; 133 107371. ( PubMed , DOI )

  6. Amy C Fan, Yusuke Nakauchi, Lawrence Bai, Armon Azizi, Kevin A Nuno, Feifei Zhao, Thomas Köhnke, Daiki Karigane, David Cruz-Hernandez, Andreas Reinisch, Purvesh Khatri, Ravindra Majeti: RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition. Journal of Clinical Investigation. 2023.10; 133 (19): ( PubMed , DOI )

  7. Asuka Kono, Manabu Wakamatsu, Yoshihiro Umezawa, Hideki Muramatsu, Hiroki Fujiwara, Dan Tomomasa, Kento Inoue, Keiichiro Hattori, Tetsuo Mitsui, Hidetoshi Takada, Yoshiyuki Minegishi, Yoshiyuki Takahashi, Masahide Yamamoto, Takehiko Mori, Hirokazu Kanegane: Successful treatment of DOCK8 deficiency by allogeneic hematopoietic cell transplantation from alternative donors. Int J Hematol. 2023.10; 118 (4): 519-525. ( PubMed , DOI )

  8. Fujita S, Kasahara H, Kato J, Koda Y, Shiroshita K, Yamaguchi K, Okayama M, Abe R, Kikuchi T, Shimizu T, Mori T, Kataoka K, Okamoto S: The Impact of Pretransplant Use of Tyrosine Kinase Inhibitors on Allogeneic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia-A Single-institution Retrospective Study. Internal medicine (Tokyo, Japan). 2023.10; 63 (11): 1549-1562. ( PubMed , DOI )

  9. Kohei Shiroshita, Hiroshi Kobayashi, Shintaro Watanuki, Daiki Karigane, Yuriko Sorimachi, Shinpei Tamaki, Miho Haraguchi, Masamichi Yamamoto, Ayako Nakamura-Ishizu, Shinichiro Okamoto, Keisuke Kataoka, Keiyo Takubo: Distinct roles of the preparatory and payoff phases of glycolysis in hematopoietic stem cells. Experimental Hematology. 2023.08; 124 56-67. ( PubMed , DOI )

  10. Tomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, Keiko Fujii, Tomoko Henzan, Kaoru Kahata, Rie Yamazaki, Wataru Takeda, Yoshihiro Umezawa, Kentaro Fukushima, Takashi Ashida, Minami Yamada-Fujiwara, Ryo Hanajiri, Noboru Yonetani, Yuma Tada, Yuji Shimura, Hidekazu Nishikii, Norio Shiba, Naoya Mimura, Jun Ando, Takayuki Sato, Yasuhiro Nakashima, Junko Ikemoto, Keita Iwaki, Shin-Ichiro Fujiwara, Masaki Ri, Tokiko Nagamura-Inoue, Ryuji Tanosaki, Yasuyuki Arai: Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan. Br J Haematol. 2023.07; 202 (2): 256-266. ( PubMed , DOI )

  11. Okinaka K, Inoue Y, Uchida N, Toya T, Ogawa H, Ozawa Y, Eto T, Mori T, Sugita J, Kondo T, Kato K, Suzuki R, Fukuda T: Clinical characteristics and risk factors of pneumococcal diseases in recipients of allogeneic hematopoietic stem cell transplants in the late phase: A retrospective registry study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023.07; 29 (7): 726-730. ( PubMed , DOI )

  12. Harada K, Onizuka M, Mori T, Shimizu H, Seo S, Aotsuka N, Takeda Y, Sekiya N, Kusuda M, Fujihara S, Shiraiwa S, Shono K, Shingai N, Kanamori H, Momoki M, Takada S, Mukae J, Masuda S, Mitani K, Sakaida E, Tomikawa T, Takahashi S, Usuki K, Kanda Y: Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A KSGCT Multicenter Analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2023.03; 131 79-86. ( PubMed , DOI )

  13. Yoshihiro Umezawa, Koji Sasaki: Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia. Int J Hematol. 2023.01; 117 (1): 24-29. ( PubMed , DOI )

  14. Kanda Y, Mori T, Narita A, Wolter KD, Yoshimatsu H, Nishimura K: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series. International journal of hematology. 2023.01; 117 (3): 469. ( PubMed , DOI )

  1. Kimura Shunichi, Shimizu Hiroaki, Miyazaki Takuya, Sakurai Masatoshi, Tanoue Susumu, Kayamori Kensuke, Ohwada Chikako, Yoshimura Kazuki, Nakasone Hideki, Ohashi Takuma, Shono Katsuhiro, Tachibana Takayoshi, Hatano Kaoru, Okada Keigo, Kimura Yuta, Seo Sachiko, Doki Noriko, Tanaka Masatsugu, Hatta Yoshihiro, Takahashi Satoshi, Kanda Yoshinobu: Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation BONE MARROW TRANSPLANTATION. 2022.12; ( PubMed , DOI )

  2. Nagao T, Yoshifuji K, Sadato D, Motomura Y, Saito M, Yamamoto K, Yamamoto K, Nogami A: Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12. Experimental hematology. 2022.12; 116 37-49. ( PubMed , DOI )

  3. Kohei Shiroshita, Hiroshi Kobayashi, Shintaro Watanuki, Daiki Karigane, Yuriko Sorimachi, Shinya Fujita, Shinpei Tamaki, Miho Haraguchi, Naoki Itokawa, Kazumasa Aoyoama, Shuhei Koide, Yosuke Masamoto, Kenta Kobayashi, Ayako Nakamura-Ishizu, Mineo Kurokawa, Atsushi Iwama, Shinichiro Okamoto, Keisuke Kataoka, Keiyo Takubo: A culture platform to study quiescent hematopoietic stem cells following genome editing. Cell Reports Methods. 2022.12; 2 (12): 100354. ( PubMed , DOI )

  4. Nakamura Y, Mori T, Kako S, Yamazaki H, Kanda Y, Uchida N, Tanaka M, Nawa Y, Fukuda T, Ichinohe T, Atsuta Y, Onishi Y: Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia. International journal of hematology. 2022.11; 117 (3): 356-365. ( PubMed , DOI )

  5. Nogami A., Sasaki K.: Therapeutic Advances in Immunotherapies for Hematological Malignancies Therapeutic Advances in Immunotherapies for Hematological Malignancies. International Journal of Molecular Sciences . 2022.09; 23 11526.

  6. Nogawa M, Watanabe N, Koike T, Fukuda K, Ishiguro M, Fujino H, Hirayama J, Shiba M, Handa M, Mori T, Okamoto S, Miyata S, Satake M.: Hemostatic function of cold‐stored platelets in a thrombocytopenic rabbit bleeding model Transfusion. 2022.09; 62 (11): 2304-2313. ( PubMed , DOI )

  7. Yokoyama Y, Nozawa E, Morita M, Ishikawa E, Mori T, Sakurai M, Kikuchi T, Matsuki E, Yamazaki R, Kataoka K, Jibiki A, Kawazoe H, Suzuki S, Nakamura T: Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high-performance liquid chromatography-Photodiode array detection. Journal of clinical laboratory analysis. 2022.08; 36 (8): e24598. ( PubMed , DOI )

  8. Noji R, Tohyama K, Kugimoto T, Kuroshima T, Hirai H, Tomioka H, Michi Y, Tasaki A, Ohno K, Ariizumi Y, Onishi I, Suenaga M, Mori T, Okamoto R, Yoshimura R, Miura M, Asakage T, Miyake S, Ikeda S, Harada H, Kano Y: Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer. Cancers. 2022.07; 14 (14): ( PubMed , DOI )

  9. Mizuno K, Sakurai M, Kato J, Yamaguchi K, Abe R, Koda Y, Kataoka K, Mori T: Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society. 2022.07; 24 (6): e13904. ( PubMed , DOI )

  10. Edahiro Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Kada A, Saito AM, Shimoda K, Sugimoto Y, Kurokawa T, Tomita A, Hashimoto Y, Akashi K, Matsumura I, Takenaka K, Komatsu N: Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study. International journal of hematology. 2022.07; 116 (5): 696-711. ( PubMed , DOI )

  11. Yusuke Nakauchi, Armon Azizi, Daniel Thomas, M Ryan Corces, Andreas Reinisch, Rajiv Sharma, David Cruz Hernandez, Thomas Köhnke, Daiki Karigane, Amy Fan, Daniel Martinez-Krams, Melissa Stafford, Satinder Kaur, Ritika Dutta, Paul Phan, Asiri Ediriwickrema, Erin McCarthy, Yuhong Ning, Tierney Phillips, Christopher K Ellison, Gulfem D Guler, Anna Bergamaschi, Chin-Jen Ku, Samuel Levy, Ravindra Majeti: The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia. Blood Cancer Discovery. 2022.07; 3 (4): 346-367. ( PubMed , DOI )

  12. Yokota T, Ueno T, Soga Y, Ishiki H, Uezono Y, Mori T, Zenda S, Uchitomi Y.: J-SUPPORT research policy for oral mucositis associated with cancer treatment Cancer Med. 2022.06; 11 (24): 4816-4829. ( PubMed , DOI )

  13. Masahide Yamamoto, Maho Sato, Yasushi Onishi, Yoji Sasahara, Hideki Sano, Masayoshi Masuko, Hirohisa Nakamae, Ken-Ichi Matsuoka, Takahide Ara, Kana Washio, Makoto Onizuka, Kenichiro Watanabe, Yoshiyuki Takahashi, Tsuneaki Hirakawa, Miwako Nishio, Chizuko Sakashita, Tohru Kobayashi, Akihisa Sawada, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Hashii, Yoshiko Atsuta, Ayako Arai: Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan. Am J Hematol. 2022.06; 97 (6): 780-790. ( PubMed , DOI )

  14. Tsuyoshi Nakagawa, Kumiko Hayashi, Ayumi Ogawa, Goshi Oda, Iichiro Onishi, Masahide Yamamoto, Mio Mori, Tomoyuki Fujioka, Toshiaki Ishikawa, Kentaro Okamoto, Hiroyuki Uetake: Bone Marrow Carcinomatosis in a Stage IV Breast Cancer Patient Treated by Letrozole as First-Line Endocrine Therapy. Case Rep Oncol. 2022.04; 15 (1): 436-441. ( PubMed , DOI )

  15. Satoru Aoyama, Shunichiro Yasuda, Huixin Li, Daisuke Watanabe, Yoshihiro Umezawa, Keigo Okada, Ayako Nogami, Osamu Miura, Norihiko Kawamata: A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cell‑surface proteins on target cells. International Journal of Molecular Medicine. 2022.04; 49 (4): ( PubMed , DOI )

  16. Sekiya T, Kasahara H, Takemura R, Fujita S, Kato J, Doki N, Katayama Y, Ozawa Y, Takada S, Eto T, Fukuda T, Ichinohe T, Takanashi M, Onizuka M, Atsuta Y, Okamoto S, Yoshimura A, Takaki S, Mori T: Essential Roles of the Transcription Factor NR4A1 in Regulatory T Cell Differentiation under the Influence of Immunosuppressants. Journal of immunology (Baltimore, Md. : 1950). 2022.04; 208 (9): 2122-2130. ( PubMed , DOI )

  17. Tachibana T, Kondo T, Uchida N, Doki N, Takada S, Takahashi S, Yano S, Mori T, Kohno A, Kimura T, Fukuda T, Atsuta Y, Nagamura-Inoue T, On-Behalf-Of-The-Adult-Cmlmpn-Working-Group-Of-The-Japanese-Society-For-Transplantation-And-Cellular-Therapy: The clinical significance of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive chronic myeloid leukemia who underwent allogeneic hematopoietic cell transplantation. Transplantation and cellular therapy. 2022.03; 28 (6): 321.e1-321.e8. ( PubMed , DOI )

  18. Karigane D, Haraguchi M, Toyama-Sorimachi N, Nishimura EK, Takubo K: Mitf is required for T cell maturation by regulating dendritic cell homing to the thymus. Biochemical and biophysical research communications. 2022.03; 596 29-35. ( PubMed , DOI )

  19. Hashimoto Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Kada A, Saito AM, Shimoda K, Sugimoto Y, Kurokawa T, Tomita A, Edahiro Y, Akashi K, Matsumura I, Takenaka K, Komatsu N: Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study. International journal of hematology. 2022.02; 115 (2): 208-221. ( PubMed , DOI )

  20. Aya Usami, Kota Yokoyama, Junichi Tsuchiya, Yoshihiro Umezawa, Kazuma Toda, Ukihide Tateishi, Ryoichi Yoshimura: F]FDG Avidity and Low EOB Uptake Proportional to the Irradiation Dose. Diagnostics (Basel). 2022.02; 12 (2): ( PubMed , DOI )

  21. Motomura Y, Umezawa Y, Arimatsu T, Okada K, Miura O, Kumagai T: Successful treatment with bortezomib for refractory fever associated with myelodysplastic syndrome with underlying lymphoplasmacytic lymphoma. Clinical case reports. 2022.02; 10 (2): e05372. ( PubMed , DOI )

  22. Hashimoto Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Kada A, Saito AM, Shimoda K, Sugimoto Y, Kurokawa T, Tomita A, Edahiro Y, Akashi K, Matsumura I, Takenaka K, Komatsu N.: Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study Int J Hematol. . 2022.02; 115 208-221.

  23. Takase H, Arai A, Iwasaki Y, Imai A, Nagao T, Kawagishi M, Ishida T, Mochizuki M: Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches. Progress in retinal and eye research. 2022.02; 90 101053. ( PubMed , DOI )

  24. Masatoshi Sakurai, Yasuhito Nannya, Rie Yamazaki, Kentaro Yamaguchi, Yuya Koda, Ryohei Abe, Kenji Yokoyama, Seishi Ogawa, Takehiko Mori: Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies. Ann Hematol. 2022.01; 101 (1): 237-239. ( PubMed , DOI )

  25. Nobuhiro Hiramoto, Hirohito Yamazaki, Yukinori Nakamura, Naoyuki Uchida, Makoto Murata, Tadakazu Kondo, Satoshi Yoshioka, Tetsuya Eto, Akinori Nishikawa, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Yasushi Onishi, Ritsuro Suzuki, Takehiko Mori, : Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation. Ann Hematol. 2022.01; 101 (1): 165-175. ( PubMed , DOI )

  26. Hirohisa Nakamae, Masahide Yamamoto, Emiko Sakaida, Yoshinobu Kanda, Ken Ohmine, Takaaki Ono, Itaru Matsumura, Maho Ishikawa, Makoto Aoki, Akio Maki, Hirohiko Shibayama: Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial. Int J Hematol. 2022.01; 115 (1): 33-42. ( PubMed , DOI )

  27. Takehiko Mori, Yuya Koda, Jun Kato, Masatoshi Sakurai, Yoshifumi Uwamino, Naoki Hasegawa: Usefulness of the FilmArray Meningitis/Encephalitis Panel in diagnosis of central nervous system infection after allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2022.01; 30 (1): 5-8. ( PubMed , DOI )

  28. Kawajiri A, Kawase T, Tanaka H, Fukuda T, Mukae J, Ozawa Y, Eto T, Uchida N, Mori T, Ashida T, Kondo T, Onizuka M, Ichinohe T, Atsuta Y, Morishima S, Kanda J, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation. Bone marrow transplantation. 2022.01; 57 (3): 407-415. ( PubMed , DOI )

  1. Kamiya T, Sakurai M, Kikuchi T, Okayama M, Mizuno K, Tanigawa T, Koda Y, Kato J, Mori T: Efficacy of ondansetron against emesis induced by a multiple-day cisplatin-based chemotherapy regimen for malignant lymphoma. Hematology (Amsterdam, Netherlands). 2021.12; 26 (1): 945-949. ( PubMed , DOI )

  2. Efficacy of ondansetron against emesis induced by a multiple-day cisplatin-based chemotherapy regimen for malignant lymphoma Hematology. 2021.12; 26 (1): 945-949.

  3. Takayoshi Tachibana, Junya Kanda, Takuma Ishizaki, Yuho Najima, Masatsugu Tanaka, Noriko Doki, Shin-Ichiro Fujiwara, Shun-Ichi Kimura, Makoto Onizuka, Satoshi Takahashi, Takeshi Saito, Takehiko Mori, Shin Fujisawa, Emiko Sakaida, Takuya Miyazaki, Nobuyuki Aotsuka, Moritaka Gotoh, Reiko Watanabe, Katsuhiro Shono, Heiwa Kanamori, Yoshinobu Kanda, Shinichiro Okamoto, : Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis Ann Hematol. 2021.11; 100 (11): 2763-2771. ( PubMed , DOI )

  4. Shunichiro Yasuda, Satoru Aoyama, Ryoto Yoshimoto, Huixin Li, Daisuke Watanabe, Hiroki Akiyama, Kouhei Yamamoto, Takeo Fujiwara, Yuho Najima, Noriko Doki, Emiko Sakaida, Yoko Edahiro, Misa Imai, Marito Araki, Norio Komatsu, Osamu Miura, Norihiko Kawamata: MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations. Int J Hematol. 2021.10; 114 (4): 424-440. ( PubMed , DOI )

  5. Yuji Sekine, Kouhei Yamamoto, Morito Kurata, Ayaka Honda, Iichiroh Onishi, Yuko Kinowaki, Genji Kawade, Shiori Watabe, Serina Nomura, Sho Fukuda, Sachiko Ishibashi, Masumi Ikeda, Masahide Yamamoto, Masanobu Kitagawa: HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma. Pathology. 2021.09; (21): 435-439. ( PubMed , DOI )

  6. Hideki Nakasone, Shinichi Kako, Takayoshi Tachibana, Masatsugu Tanaka, Makoto Onizuka, Satoshi Takahashi, Akira Yokota, Shin-Ichiro Fujiwara, Toru Sakura, Emiko Sakaida, Shin Fujisawa, Rie Yamazaki, Moritaka Gotoh, Maki Hagihara, Nobuyuki Aotsuka, Nobuhiro Tsukada, Yoshihiro Hatta, Hiroaki Shimizu, Kensuke Usuki, Reiko Watanabe, Takehiko Mori, Shingo Yano, Heiwa Kanamori, Yoshinobu Kanda: Novel Indicators of Transplant Outcomes for PhALL: Current Molecular-Relapse-Free Survival. Transplant Cell Ther. 2021.09; 27 (9): 800.e1-800.e8. ( PubMed , DOI )

  7. Shunichiro Yasuda, Yuho Najima, Tatsuya Konishi, Yuta Yamada, Akihito Nagata, Toshiaki Takezaki, Satoshi Kaito, Shuhei Kurosawa, Masahiro Sakaguchi, Kaito Harada, Naoki Shingai, Kosuke Yoshioka, Kyoko Inamoto, Junichi Mukae, Takashi Toya, Aiko Igarashi, Hiroaki Shimizu, Takeshi Kobayashi, Kazuhiko Kakihana, Hisashi Sakamaki, Norihiko Kawamata, Kazuteru Ohashi, Noriko Doki: Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study. Leuk Res. 2021.09; 108 106627. ( PubMed , DOI )

  8. Saiko Kurosawa, Takuhiro Yamaguchi, Ayako Mori, Tomoko Matsuura, Takehiko Mori, Masatsugu Tanaka, Tadakazu Kondo, Yukari Umemoto, Hideki Goto, Satoshi Yoshioka, Shinichiro Machida, Takahiko Sato, Yuta Katayama, Seiko Kato, Katsuhiro Shono, Ishikazu Mizuno, Shin-Ichiro Fujiwara, Akio Kohno, Miyako Takahashi, Takahiro Fukuda: Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up. J Cancer Surviv. 2021.08; 16 (5): 1004-1015. ( PubMed , DOI )

  9. Ikuko Hirai, Takeru Funakoshi, Hajime Kamijuku, Keitaro Fukuda, Mariko Mori, Masatoshi Sakurai, Yuya Koda, Jun Kato, Takehiko Mori, Naohide Watanabe, Shinobu Noji, Tomonori Yaguchi, Takashi Iwata, Shigeki Ohta, Tomonobu Fujita, Ryuji Tanosaki, Makoto Handa, Shinichiro Okamoto, Masayuki Amagai, Yutaka Kawakami: Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors. Cancer Sci. 2021.08; 112 (8): 3163-3172. ( PubMed , DOI )

  10. Konishi Tatsuya, Kusakabe Shinsuke, Hino Akihisa, Inamoto Kyoko, Yoshifuji Kota, Kiridoshi Yuko, Takeshita Kozue, Sasajima Satoshi, Toya Takashi, Igarashi Aiko, Najima Yuho, Kobayashi Takeshi, Doki Noriko, Motooka Daisuke, Nakamura Shota, Suyama Masahiro, Suda Wataru, Shiota Atsushi, Atarashi Koji, Hattori Masahira, Honda Kenya, Yokota Takafumi, Ohashi Kazuteru, Shibayama Hirohiko, Fukushima Kentaro, Kakihana Kazuhiko: Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease BONE MARROW TRANSPLANTATION. 2021.07; 56 (7): 1728-1731. ( DOI )

  11. Mori T, Kikuchi T, Koh M, Koda Y, Yamazaki R, Sakurai M, Tomita Y, Ozawa Y, Kohashi S, Abe R, Saburi M, Kato J: Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening. Bone marrow transplantation. 2021.06; 56 (6): 1266-1271. ( PubMed , DOI )

  12. Uno S, Takano Y, Iketani O, Abiko T, Miwa T, Nanki K, Kurihara T, Tamura Y, Ara M, Uwamino Y, Shinjoh M, Mori T, Hasegawa N: Digestive Decolonization of Colorectal Carriage of Vancomycin-resistant Enterococcus faecium in a Japanese Adult: A Case Report. Internal medicine . 2021.06; 61 (2): 249-252. ( PubMed , DOI )

  13. Sakurai M, Mori T, Kato K, Kanaya M, Mizuno S, Shiratori S, Wakayama T, Uchida N, Kobayashi H, Kubo K, Amano I, Ohta T, Miyazaki Y, Kanda J, Fukuda T, Atsuta Y, Kondo E, Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).: Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation. Bone marrow transplantation. 2021.06; 56 (6): 1462-1466. ( PubMed , DOI )

  14. Mori T, Kikuchi T, Yamazaki R, Koda Y, Saburi M, Sakurai M, Shigematsu N, Okamoto S, Kato J: Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation. International journal of hematology. 2021.06; 113 (6): 877-883. ( PubMed , DOI )

  15. Nakasone H, Kako S, Mori T, Takahashi S, Onizuka M, Fujiwara SI, Sakura T, Sakaida E, Yokota A, Aotsuka N, Hagihara M, Tsukada N, Hatta Y, Usuki K, Watanabe R, Gotoh M, Fujisawa S, Yano S, Kanamori H, Okamoto S, Kanda Y: Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia. Bone marrow transplantation. 2021.06; 56 (6): 1402-1412. ( PubMed , DOI )

  16. Kota Yoshifuji, Takashi Toya, Noriyo Yanagawa, Fumikazu Sakai, Akihito Nagata, Noritaka Sekiya, Kazuteru Ohashi, Noriko Doki: CT classification of acute myeloid leukemia with pulmonary infiltration Japanese Journal of Radiology. 2021.06; 39 (11): 1049-1058. ( PubMed , DOI )

  17. Amikura T, Kikuchi T, Kato J, Koda Y, Sakurai M, Yamazaki R, Mikita K, Saburi M, Nakazato T, Mori T: Toxoplasmosis after allogeneic hematopoietic stem cell transplantation: Impact of serostatus-based management. Transplant infectious disease : an official journal of the Transplantation Society. 2021.06; 23 (3): e13506. ( PubMed , DOI )

  18. Masayuki Nagasawa, Noriko Mitsuiki, Masakatsu Yanagimachi, Masahide Yamamoto, Tetsuya Fukuda, Osamu Miura, Ryutaro Oba, Akira Igarashi, Kinya Nagata, Tomohiro Morio: Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD. Int J Hematol. 2021.06; 113 (6): 910-920. ( PubMed , DOI )

  19. Kurosawa S, Kaito S, Uchida N, Fukuda T, Doki N, Mori T, Hasegawa Y, Takada S, Sakaida E, Tanaka M, Ikegame K, Kanda J, Atsuta Y, Kako S: Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia with high hyperdiploidy: a retrospective nationwide study. Leukemia & lymphoma. 2021.05; 62 (10): 1-7. ( PubMed , DOI )

  20. Kaori Uchino, Lam Vu Quang, Shohei Mizuno, Tomohiro Horio, Hidesuke Yamamoto, Ichiro Hanamura, Yoshihisa Kodera, J Luis Espinoza, Makoto Onizuka, Koichi Kashiwase, Yasuo Morishima, Takahiro Fukuda, Noriko Doki, Koichi Miyamura, Takehiko Mori, Eriko Morishita, Shinji Nakao, Akiyoshi Takami: Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation. Genes Immun. 2021.05; 22 (1): 35-43. ( PubMed , DOI )

  21. Keigo Okada, Hiroki Fujiwara, Tomoyuki Arimatsu, Yotaro Motomura, Tsuyoshi Kato, Naoki Takezako, Takashi Kumagai: Efficacy and Safety of Balloon Kyphoplasty for Pathological Vertebral Fractures in Patients with Hematological Malignancies in Our Institution. Intern Med. 2021.04; 60 (8): 1169-1174. ( PubMed , DOI )

  22. Karigane D, Kasahara H, Shiroshita K, Fujita S, Kobayashi H, Tamaki S, Yamazaki R, Yahagi K, Yatabe Y, Kondoh N, Arai T, Katagiri H, Shimizu N, Sakurai M, Kikuchi T, Kato J, Shimizu T, Hayakawa T, Yaguchi T, Matsushita M, Nakajima H, Kawakami Y, Murata M, Mori T, Sasaki T, Okamoto S, Takubo K: Detection of residual disease in chronic myeloid leukemia utilizing genomic next generation sequencing reveals persistence of differentiated Ph+ B cells but not bone marrow stem/progenitors. Leukemia & lymphoma. 2021.03; 62 (3): 679-687. ( PubMed , DOI )

  23. Fujimoto A, Anzai T, Fukuda T, Uchida N, Ohta T, Mori T, Sawa M, Yoshioka S, Miyamoto T, Uchiyama H, Katayama Y, Matsuoka KI, Shiratori S, Nakazawa H, Kanda J, Ichinohe T, Atsuta Y, Fujita N, Kondo E, Suzuki R: Impact of event-free survival status after stem cell transplantation on subsequent survival of patients with lymphoma. Blood advances. 2021.03; 5 (5): 1412-1424. ( PubMed , DOI )

  24. Morishima S, Fukuda T, Doki N, Mori T, Onizuka M, Kawakita T, Kato C, Ozawa Y, Tanaka M, Kurokawa M, Kamimura T, Inoue M, Tanaka J, Ichinohe T, Atsuta Y, Morishima Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors. Bone marrow transplantation. 2021.03; 56 (3): 646-654. ( PubMed , DOI )

  25. Yuki Fukawa, Kei Sakamoto, Takuma Kugimoto, Yasuyuki Michi, Hiroyuki Harada, Masahide Yamamoto, Masanobu Kitagawa, Tohru Ikeda, Kouhei Yamamoto: Nodular lymphocyte-predominant Hodgkin lymphoma involving the hard palate. Pathol Int. 2021.03; 71 (3): 213-215. ( PubMed , DOI )

  26. Morikawa S, Tsunoda K, Miyashita Y, Nasu M, Horie N, Usuda S, Kato J, Mori T, Nakagawa T: Management of generalized severe periodontitis using full-mouth disinfection and systemic antibiotics in a leukemic patient before stem cell transplantation: A case report. Clinical case reports. 2021.02; 9 (2): 644-649. ( PubMed , DOI )

  27. Izumi Y, Kanayama M, Shen Z, Kai M, Kawamura S, Akiyama M, Yamamoto M, Nagao T, Okada K, Kawamata N, Toyota S, Ohteki T: An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy. Frontiers in immunology. 2021.02; 12 618081. ( PubMed , DOI )

  28. Ueda N, Konuma T, Aoki J, Takahashi S, Ozawa Y, Mori T, Ota S, Eto T, Takada S, Yoshioka S, Shiratori S, Kako S, Onizuka M, Fukuda T, Kanda Y, Atsuta Y, Yanada M: Prognostic Impact of the Fractionation of Total Body Irradiation for Patients with Acute Myeloid Leukemia Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation. Transplantation and cellular therapy. 2021.02; 27 (2): 185.e1-185.e6. ( PubMed , DOI )

  29. Nakayama H, Yamazaki R, Kato J, Koda Y, Sakurai M, Mori T: Impact of Specific Antibody Level on Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation. Transplantation and cellular therapy. 2021.02; 27 (2): 174.e1-174.e5. ( PubMed , DOI )

  30. Onishi Y, Mori T, Yamazaki H, Takenaka K, Yamaguchi H, Shingai N, Ozawa Y, Iida H, Ota S, Uchida N, Miyamoto T, Katayama Y, Kato J, Yoshioka S, Onizuka M, Ichinohe T, Atsuta Y, Adult Aplastic Anemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia. Annals of hematology. 2021.01; 100 (1): 217-228. ( PubMed , DOI )

  31. Maryam Aftabizadeh, Yi-Jia Li, Qianqian Zhao, Chunyan Zhang, Nigus Ambaye, Jieun Song, Toshikage Nagao, Christoph Lahtz, Marwan Fakih, David K Ann, Hua Yu, Andreas Herrmann: Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis. JCI Insight. 2021.01; 6 (2): ( PubMed , DOI )

  32. Nakamura Y, Takenaka K, Yamazaki H, Onishi Y, Ozawa Y, Ikegame K, Matsuoka KI, Toubai T, Ueda Y, Kanda Y, Ichinohe T, Atsuta Y, Mori T: Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria. International journal of hematology. 2021.01; 113 (1): 122-127. ( PubMed , DOI )

  33. Takenaka K, Onishi Y, Mori T, Hirakawa T, Tada Y, Uchida N, Kobayashi T, Kanda Y, Ozawa Y, Ota S, Iida H, Fukushima K, Kimua T, Fukuda T, Atsuta Y, Matsuto K, Yamazaki H, Nakasone H: Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation. Transplantation and cellular therapy. 2021.01; 27 (1): 82.e1-82.e8. ( PubMed , DOI )

  34. Kikuchi T, Mori T, Ohwada C, Onoda M, Shimizu H, Yokoyama H, Onizuka M, Koda Y, Kato J, Takeda Y, Hino Y, Mishina T, Sakaida E, Shono K, Nagao Y, Yokota A, Matsumoto K, Morita K, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).: Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine. International journal of hematology. 2021.01; 113 (1): 128-133. ( PubMed , DOI )

  35. Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Miyazaki T, Aotsuka N, Gotoh M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).: Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter Analysis. Transplantation and cellular therapy. 2021.01; 27 (1): 70.e1-70.e8. ( PubMed , DOI )

  36. Kuboki Mai, Umezawa Yoshihiro, Motomura Yotaro, Okada Keigo, Nogami Ayako, Nagao Toshikage, Miura Osamu, Yamamoto Masahide: Severe Motor Weakness Due to Disturbance in Peripheral Nerves Following Tisagenlecleucel Treatment IN VIVO. 2021; 35 (6): 3407-3411. ( PubMed , DOI )

  37. Yuriko Sorimachi, Daiki Karigane, Yukako Ootomo, Hiroshi Kobayashi, Takayuki Morikawa, Kinya Otsu, Yoshiaki Kubota, Shinichiro Okamoto, Nobuhito Goda, Keiyo Takubo: p38α plays differential roles in hematopoietic stem cell activity dependent on aging contexts. Journal of Biological Chemistry. 2021; 296 100563. ( PubMed , DOI )

  1. Konuma T, Ishiyama K, Igarashi A, Uchida N, Ozawa Y, Fukuda T, Ueda Y, Matsuoka KI, Mori T, Katayama Y, Onizuka M, Ichinohe T, Atsuta Y, Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020.12; 26 (24): 6483-6493. ( PubMed , DOI )

  2. Abe R, Mori T, Tanigawa T, Koda Y, Hosoe N, Sakurai M, Kikuchi T, Kato J, Shimizu T, Ogata H, Kanai T, Sasaki A, Kameyama K, Okamoto S: Clinical characteristics and outcomes of duodenal-type follicular lymphoma. Leukemia & lymphoma. 2020.12; 61 (13): 3266-3268. ( PubMed , DOI )

  3. Takehiko Mori, Masuho Saburi, Maki Hagihara, Masaaki Mori, Rie Yamazaki, Jun Kato: Long-term remission of cryopyrin-associated periodic syndrome after allogeneic haematopoietic stem cell transplantation. Ann Rheum Dis. 2020.11; ( PubMed , DOI )

  4. Fujita H, Sasaki T, Miyamoto T, Akutsu SN, Sato S, Mori T, Nakabayashi K, Hata K, Suzuki H, Kosaki K, Matsuura S, Matsubara Y, Amagai M, Kubo A: Premature aging syndrome showing random chromosome number instabilities with CDC20 mutation. Aging cell. 2020.11; 19 (11): e13251. ( PubMed , DOI )

  5. Mori T, Mikita K, Koda Y, Sakurai M, Saburi M, Hasegawa N, Kato J: Seroprevalence of Toxoplasma gondii among Japanese adults with hematological diseases. International journal of hematology. 2020.11; 112 (5): 755-756. ( PubMed , DOI )

  6. Towako Taguchi, Morito Kurata, Iichiroh Onishi, Yuko Kinowako, Yunosuke Sato, Sayuri Shiono, Sachiko Ishibashi, Masumi Ikeda, Masahide Yamamoto, Masanobu Kitagawa, Kouhei Yamamoto: SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma. Lab Invest. 2020.10; ( PubMed , DOI )

  7. Yanada M, Fukuda T, Tanaka M, Ota S, Toya T, Mori T, Uchida N, Ozawa Y, Nakamae H, Kanda Y, Ichinohe T, Atsuta Y, Yano S: Long-term results of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia: a retrospective analysis of 10-year follow-up data. Bone marrow transplantation. 2020.10; 55 (10): 2008-2016. ( PubMed , DOI )

  8. 田畑 真梨子, 佐藤 悠佑, 木暮 泰寛, McClure Marni B., 斎藤 優樹, 新垣 清登, 吉藤 康太, 古屋 淳史, 河野 隆志, 白石 友一, 久米 春喜, 片岡 圭亮: がん分子標的治療薬・がん免疫治療薬への抵抗性に関わる分子機構とその克服　遺伝性淡明細胞型腎細胞癌における腫瘍内または腫瘍間の遺伝的、免疫的不均一性 日本癌学会総会記事. 2020.10; 79回 S4-3. ( 医中誌 )

  9. 古屋 淳史, 斎藤 優樹, 亀田 拓郎, 木暮 泰寛, McClure Marni B., 新垣 清登, 吉藤 康太, 田畑 真梨子, 下田 和哉, 片岡 圭亮: がんの一細胞生物学　マルチオミクス単一細胞解析によるHTLV-1感染状態およびATLにおける細胞動態の網羅的解明 日本癌学会総会記事. 2020.10; 79回 S12-3. ( 医中誌 )

  10. Kota Yoshifuji, Kyoko Inamoto, Yuko Kiridoshi, Kozue Takeshita, Satoshi Sasajima, Yukiko Shiraishi, Yuko Yamashita, Yuko Nisaka, Yukari Ogura, Rie Takeuchi, Takashi Toya, Aiko Igarashi, Yuho Najima, Noriko Doki, Takeshi Kobayashi, Kazuteru Ohashi, Wataru Suda, Koji Atarashi, Atsushi Shiota, Masahira Hattori, Kenya Honda, Kazuhiko Kakihana: Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation. Blood Adv. 2020.10; 4 (19): 4607-4617. ( PubMed , DOI )

  11. Mori T, Shiratori S, Suzumiya J, Kurokawa M, Shindo M, Naoyuki U, Katsuto T, Miyamoto T, Morishige S, Hirokawa M, Fukuda T, Atsuta Y, Suzuki R: Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome. Hematological oncology. 2020.08; 38 (3): 266-271. ( PubMed , DOI )

  12. Ichiro Yonese, Chizuko Sakashita, Ken-Ichi Imadome, Tohru Kobayashi, Masahide Yamamoto, Akihisa Sawada, Yoshinori Ito, Noriko Fukuhara, Asao Hirose, Yusuke Takeda, Masanori Makita, Tomoyuki Endo, Shun-Ichi Kimura, Masataka Ishimura, Osamu Miura, Shouichi Ohga, Hiroshi Kimura, Shigeyoshi Fujiwara, Ayako Arai: Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020.07; 4 (13): 2918-2926. ( PubMed , DOI )

  13. Sakurai M, Mori T, Uchiyama H, Ago H, Iwato K, Eto T, Iwasaki H, Kawata T, Takamatsu H, Yamasaki S, Takanashi M, Ichinohe T, Atsuta Y, Suzuki R: Outcome of stem cell transplantation for Waldenström's macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group. Annals of hematology. 2020.07; 99 (7): 1635-1642. ( PubMed , DOI )

  14. Kikuchi T, Kato J, Koda Y, Sakurai M, Hayashi Y, Mori T: Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF-producing multiple myeloma. Annals of hematology. 2020.07; 99 (7): 1667-1668. ( PubMed , DOI )

  15. Tachibana T, Ishizaki T, Takahashi S, Najima Y, Kimura SI, Sakaida E, Onizuka M, Mori T, Fujisawa S, Fujiwara SI, Saito T, Hagihara M, Aotsuka N, Gotoh M, Usuki K, Tsukada N, Kanda J, Kanamori H, Kanda Y, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).: Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis. Bone marrow transplantation. 2020.07; 55 (7): 1497-1501. ( PubMed , DOI )

  16. Toyama T, Mori T, Kato J, Sugita K, Hasegawa N, Nakata N, Hoshino Y, Okamoto S: Disseminated Mycobacterium massiliense infection in a patient with myelodysplastic syndrome undergoing allogeneic bone marrow transplantation. Transplant infectious disease : an official journal of the Transplantation Society. 2020.06; 22 (3): e13278. ( PubMed , DOI )

  17. Kato M, Nakasone H, Nakano N, Fuji S, Shinohara A, Yokoyama H, Sakashita K, Hori T, Takahashi S, Nara M, Kanda Y, Mori T, Takita J, Kawaguchi H, Kawakita T, Ichinohe T, Fukuda T, Atsuta Y, Ogata M, Transplantation Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation. 2020.06; 55 (6): 1023-1028. ( PubMed , DOI )

  18. Kurosawa S, Mori A, Tsukagoshi M, Onishi Y, Ohwada C, Mori T, Goto H, Asano-Mori Y, Nawa Y, Hino M, Fukuchi T, Mori Y, Yamahana R, Inamoto Y, Fukuda T: Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in Japan. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020.05; 26 (5): 949-955. ( PubMed , DOI )

  19. Kawamura K, Kanda J, Ohashi K, Fukuda T, Iwato K, Eto T, Fujiwara SI, Mori T, Fukushima K, Ozawa Y, Uchida N, Ashida T, Ichinohe T, Atsuta Y, Kanda Y: Influence of HLA 1-3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation. Annals of hematology. 2020.05; 99 (5): 1099-1110. ( PubMed , DOI )

  20. Sakurai M, Takemoto H, Mori T, Okamoto S, Yamazaki S: In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide. International journal of hematology. 2020.05; 111 (5): 739-741. ( PubMed , DOI )

  21. Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Matsumoto K, Aotsuka N, Gotoh M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).: Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020.05; 26 (5): 998-1004. ( PubMed , DOI )

  22. Ikeda K, Ohto H, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Muroi K, Mori T, Kasama K, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Kanda J, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Minakawa K, Tanosaki R: Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study. Transfusion. 2020.05; 60 (5): 1015-1023. ( PubMed , DOI )

  23. Correa MEP, Cheng KKF, Chiang K, Kandwal A, Loprinzi CL, Mori T, Potting C, Rouleau T, Toro JJ, Ranna V, Vaddi A, Peterson DE, Bossi P, Lalla RV, Elad S: Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2020.05; 28 (5): 2449-2456. ( PubMed , DOI )

  24. Uekusa T, Sato R, Yoo D, Kawamoto T, Mori T: Transistor Characteristics of Charge-Transfer Complexes Observed across a Neutral-Ionic Transition. ACS applied materials & interfaces. 2020.05; 12 (21): 24174-24183. ( PubMed , DOI )

  25. Shiroshita K, Mori T, Kato J, Sakurai M, Koda Y, Abe R, Murakami K, Sumiya C, Fujita S, Yamaguchi K, Yamazaki R, Nakayama H, Suzuki S, Nakahara J, Okamoto S: Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention. Bone marrow transplantation. 2020.05; 55 (5): 939-945. ( PubMed , DOI )

  26. Mori T, Kikuchi T, Kato J, Koda Y, Sakurai M, Kikumi O, Inose R, Murata M, Hasegawa N, Nakayama H, Yamazaki R, Okamoto S: Seasonal changes in indoor airborne fungal concentration in a hematology ward. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2020.04; 26 (4): 363-366. ( PubMed , DOI )

  27. Shunya Matsumoto, Toshiki Kijima, Yoh Matsuoka, Masahide Yamamoto, Yasuhisa Fujii: A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab. Eur. J. Cancer. 2020.03; ( PubMed , DOI )

  28. Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, Maeda T, Kato J, Ishiyama K, Matsuoka KI, Miyamoto T, Iida H, Ikegame K, Fukuda T, Ichinohe T, Atsuta Y, Mori T, Adult Aplastic Anemia Working Group of the Japanese Society for Hematopoietic Cell Transplantation.: Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020.03; 26 (3): 445-450. ( PubMed , DOI )

  29. Kako S, Kanda Y, Onizuka M, Aotsuka N, Usuki K, Tachibana T, Kobayashi T, Kato J, Yano S, Shimizu H, Shono K, Tanaka M, Tsukamoto S, Mori T, Yamazaki E, Najima Y, Hangaishi A, Hoshino T, Watanabe R, Matsumoto K, Okamoto S, for Kanto Study Group for Cell Therapy (KSGCT).: Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study. American journal of hematology. 2020.03; 95 (3): 251-257. ( PubMed , DOI )

  30. Horio T, Morishita E, Mizuno S, Uchino K, Hanamura I, Espinoza JL, Morishima Y, Kodera Y, Onizuka M, Kashiwase K, Fukuda T, Doki N, Miyamura K, Mori T, Nakao S, Takami A: Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients. Cancers. 2020.02; 12 (2): ( PubMed , DOI )

  31. Iida M, Nakasone H, Yamashita T, Inoue M, Ishida Y, Uchiyama H, Katayama Y, Miyamoto T, Yoshioka S, Shiratori S, Mori T, Sawa M, Sugio Y, Fukuda T, Ichinohe T, Atsuta Y, Inamoto Y, Late Effect and Quality of Life Working Group of the Japan Society for Hematopoietic Cell Transplantation: Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation. Blood cell therapy. 2020.02; 3 (1): 11-17. ( PubMed , DOI )

  32. Koji Nishikawa, Kiminori Kimura, Yoshinobu Kanda, Masaya Sugiyama, Kazuhiko Kakihana, Noriko Doki, Kazuteru Ohashi, Sung Kwan Bae, Kazuhiro Takahashi, Yuko Ishihara, Ishikazu Mizuno, Yasushi Onishi, Masahiro Onozawa, Makoto Onizuka, Masahide Yamamoto, Tetsuya Ishikawa, Kazuaki Inoue, Shigeru Kusumoto, Satoshi Hashino, Hidetsugu Saito, Tatsuya Kanto, Hisashi Sakamaki, Masashi Mizokami: A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation. Bone Marrow Transplant.. 2020.02; ( PubMed , DOI )

  33. Ohwada C, Sakaida E, Igarashi A, Kobayashi T, Doki N, Mori T, Kato J, Koda Y, Kanamori H, Tanaka M, Tachibana T, Fujisawa S, Nakajima Y, Numata A, Toyosaki M, Aoyama Y, Onizuka M, Hagihara M, Koyama S, Kanda Y, Nakasone H, Shimizu H, Kato S, Watanabe R, Shono K, Sakai R, Saito T, Nakaseko C, Okamoto S: A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020.01; 26 (1): 162-170. ( PubMed , DOI )

  34. Murata M, Suzuki R, Nishida T, Shirane S, Shimazu Y, Minami Y, Mori T, Doki N, Kanda Y, Uchida N, Tanaka M, Ishikawa J, Togitani K, Fukuda T, Ichinohe T, Atsuta Y, Nagamura-Inoue T, Kiyoi H: Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis. Internal medicine (Tokyo, Japan). 2020; 59 (16): 1947-1956. ( PubMed , DOI )

  1. Kawase T, Tanaka H, Kojima H, Uchida N, Ohashi K, Fukuda T, Ozawa Y, Ikegame K, Eto T, Mori T, Miyamoto T, Hidaka M, Shiratori S, Takanashi M, Atsuta Y, Ichinohe T, Kanda Y, Kanda J, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019.12; 25 (12): 2482-2489. ( PubMed , DOI )

  2. Shimizu H, Doki N, Kanamori H, Sakura T, Mori T, Machida S, Takahashi S, Ohwada C, Fujisawa S, Yano S, Hagihara M, Kanda Y, Onoda M, Gotoh M, Kako S, Taguchi J, Usuki K, Kawai N, Aotsuka N, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT).: Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant. Bone marrow transplantation. 2019.12; 54 (12): 2020-2026. ( PubMed , DOI )

  3. Watanabe D, Nogami A, Okada K, Akiyama H, Umezawa Y, Miura O: FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM. Cancers. 2019.11; 11 (12): ( PubMed , DOI )

  4. Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Matsumoto K, Aotsuka N, Goto M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S, Kanto Study., Group for Cell Therapy (KSGCT).: Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis. Leukemia. 2019.11; 33 (11): 2610-2618. ( PubMed , DOI )

  5. Toshinobu Nishimura, Haojun Xu, Masayuki Iwasaki, Daiki Karigane, Brandon Saavedra, Yusuke Takahashi, Fabian P Suchy, Shinichiro Monobe, Renata M Martin, Manami Ohtaka, Mahito Nakanishi, Scott R Burrows, Michael L Cleary, Ravindra Majeti, Akira Shibuya, Hiromitsu Nakauchi: Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells. Gene Therapy. 2019.11; 27 (10-11): 525-534. ( PubMed , DOI )

  6. Arai Y, Kondo T, Fuse K, Shibasaki Y, Masuko M, Sugita J, Teshima T, Uchida N, Fukuda T, Kakihana K, Ozawa Y, Eto T, Tanaka M, Ikegame K, Mori T, Iwato K, Ichinohe T, Kanda Y, Atsuta Y: Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. Blood advances. 2019.11; 3 (22): 3626-3634. ( PubMed , DOI )

  7. Endo Y, Oshima G, Hibi T, Shinoda M, Sakurai M, Koda Y, Izawa Y, Obara H, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Fukushima A, Yokose T, Mori T, Kuroda T, Kitagawa Y: Achievement of Durable and Complete Remission of Graft-versus-host Disease After Liver Transplantation With Ruxolitinib: A Case Report. Transplantation. 2019.11; 103 (11): e375-e377. ( PubMed , DOI )

  8. Mizuno S, Kawamura K, Hanamura I, Sunami K, Mori T, Nakamura F, Iida S, Nakazawa H, Makita M, Kako S, Sawa M, Ueda Y, Takahashi H, Kanda Y, Ichinohe T, Atsuta Y, Takamatsu H, Takami A: Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents. Bone marrow transplantation. 2019.10; 54 (10): 1595-1604. ( PubMed , DOI )

  9. 澤 祥幸, 浜中 和子, 山田 陽子, 山本 ゆき, 齋藤 とし子, 宮本 直治, 福智 木蘭, 坂下 千瑞子, 三宅 智, 垣添 忠生: ライブアンケートを用いた参加型がんシンポジウムからみたがんサバイバーシップの展望 日本癌治療学会学術集会抄録集. 2019.10; 57回 O5-5. ( 医中誌 )

  10. Masuda K, Nakazato T, Nishiyama-Fujita Y, Ito C, Ogura S, Mizuno K, Kamiya T, Aisa Y, Mori T: Successful treatment with ponatinib for central nervous system relapse of Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia. Internal medicine journal. 2019.10; 49 (10): 1332-1334. ( PubMed , DOI )

  11. Takashi Ikeda, Keita Mori, Koji Kawamura, Takehiko Mori, Shotaro Hagiwara, Yasunori Ueda, Kaoru Kahata, Naoyuki Uchida, Nobuhiro Tsukada, Satoshi Murakami, Masahide Yamamoto, Tsutomu Takahashi, Tatsuo Ichinohe, Makoto Onizuka, Yoshiko Atsuta, Yoshinobu Kanda, Shinichiro Okamoto, Kazutaka Sunami, Hiroyuki Takamatsu: Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation. Hematol Oncol. 2019.10; ( PubMed , DOI )

  12. Kimura F, Kanda J, Ishiyama K, Yabe T, Yoshifuji K, Fukuda T, Ozawa Y, Iwato K, Eto T, Mori T, Uchida N, Ota S, Sakura T, Ichinohe T, Atsuta Y, Kanda Y, donor/source working group of the Japan Society for Hematopoietic Cell Transplantation.: ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation. Bone marrow transplantation. 2019.10; 54 (10): 1676-1685. ( PubMed , DOI )

  13. Tokuhira M, Saito S, Suzuki K, Higashi M, Momose S, Shimizu T, Mori T, Kimura Y, Amano K, Okamoto S, Takeuchi T, Tamaru JI, Kizaki M: Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders. Leukemia & lymphoma. 2019.10; 60 (10): 2508-2515. ( PubMed , DOI )

  14. Yamamoto K, Abe S, Honda A, Hashimoto J, Aizawa Y, Ishibashi S, Takemura T, Hanagata N, Yamamoto M, Miura O, Kurata M, Kitagawa M: Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma. Laboratory investigation; a journal of technical methods and pathology. 2019.09; 100 (3): 353-362. ( PubMed , DOI )

  15. Kota Yoshifuji, Yoshihiro Umezawa, Ayako Ichikawa, Ken Watanabe, Osamu Miura, Masahide Yamamoto: Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic Cases. In Vivo. 2019.09; 33 (5): 1599-1604. ( PubMed , DOI )

  16. Masahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, Toshikage Nagao, Shigeo Toyota, Osamu Miura: Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy. Anticancer Res.. 2019.09; 39 (9): 5115-5122. ( PubMed , DOI )

  17. Kato K, Mori T, Kim SW, Sawa M, Sakai T, Hashimoto H, Taguchi J, Oyake T, Kurahashi S, Imada K, Ohno H, Tanaka J, Ichinohe T, Atsuta Y, Suzuki R, Suzumiya J: Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation. Bone marrow transplantation. 2019.09; 54 (9): 1515-1517. ( PubMed , DOI )

  18. Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y: Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019.09; 25 (9): 1851-1858. ( PubMed , DOI )

  19. Nishiyama-Fujita Y, Nakazato T, Ito C, Ogura S, Mizuno K, Kamiya T, Aisa Y, Mori T: Rare case of ocular adnexal relapse with mantle cell lymphoma treated with ibrutinib monotherapy. Internal medicine journal. 2019.09; 49 (9): 1187-1189. ( PubMed , DOI )

  20. Kato H, Kato K, Kim SW, Fukuda T, Mori T, Sawa M, Ohno Y, Yoshioka S, Iwato Y, Taji H, Onizuka M, Kurahashi S, Ichinohe T, Suzumiya J, Suzuki R: Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT). British journal of haematology. 2019.09; 186 (6): e170-e175. ( PubMed , DOI )

  21. Nakayama H, Yamazaki R, Kato J, Koda Y, Sakurai M, Abe R, Watanuki S, Sumiya C, Shiroshita K, Fujita S, Yamaguchi K, Okamoto S, Mori T: Human Herpesvirus 6 Reactivation Evaluated by Digital Polymerase Chain Reaction and Its Association With Dynamics of CD134-Positive T Cells After Allogeneic Hematopoietic Stem Cell Transplantation. The Journal of infectious diseases. 2019.08; 220 (6): 1001-1007. ( PubMed , DOI )

  22. Kikuchi T, Arai M, Koda Y, Kato J, Shimizu T, Katano H, Fujii-Nishimura Y, Sakamoto M, Ebinuma H, Nakamoto N, Kanai T, Okamoto S, Mori T: Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society. 2019.08; 21 (4): e13121. ( PubMed , DOI )

  23. Shimizu R, Takeuchi M, Sakaida E, Ohwada C, Toyosaki M, Machida S, Onizuka M, Shono K, Onoda M, Saito T, Yano S, Tanaka M, Fujisawa S, Mori T, Usuki K, Takahashi S, Kanamori H, Nakaseko C, Okamoto S: Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation. Annals of hematology. 2019.07; 98 (7): 1781-1783. ( PubMed , DOI )

  24. Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Shiratori S, Miyakoshi S, Ishiyama K, Ikegame K, Matsuhashi Y, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R: Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019.07; 25 (7): 1441-1449. ( PubMed , DOI )

  25. Mizuno K, Nakazato T, Ito C, Fujita Y, Ogura S, Kamiya T, Sakurai A, Aisa Y, Mori T: The prognostic value of geriatric nutritional risk index in patients with follicular lymphoma. Annals of hematology. 2019.07; 98 (7): 1777-1779. ( PubMed , DOI )

  26. Herrmann A, Nagao T, Zhang C, Lahtz C, Li YJ, Yue C, Mülfarth R, Yu H: An effective cell-penetrating antibody delivery platform. JCI insight. 2019.07; 4 (14): ( PubMed , DOI )

  27. Yamazaki R, Kato J, Koda Y, Sakurai M, Tozawa K, Okayama M, Nakayama H, Watanuki S, Kikuchi T, Hasegawa N, Okamoto S, Mori T: Impact of immunoglobulin G2 subclass level on late-onset bacterial infection after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society. 2019.06; 21 (3): e13086. ( PubMed , DOI )

  28. Arai Kosuke, Yoshifuji Kota, Motomura Yotaro, Sonokawa Saeko, Suzuki Sayaka, Kumagai Takashi: Dasatinib for chronic myelogenous leukemia improves skin symptoms of systemic sclerosis INTERNATIONAL JOURNAL OF HEMATOLOGY. 2019.06; 109 (6): 718-722. ( PubMed , DOI )

  29. Mori T, Onishi Y, Ozawa Y, Kato C, Kai T, Kanda Y, Kurokawa M, Tanaka M, Ashida T, Sawayama Y, Fukuda T, Ichinohe T, Atsuta Y, Yamazaki H: Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia. International journal of hematology. 2019.06; 109 (6): 711-717. ( PubMed , DOI )

  30. Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda J, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT. International journal of hematology. 2019.06; 109 (6): 684-693. ( PubMed , DOI )

  31. Ishikawa A, Otaka Y, Kamisako M, Suzuki T, Miyata C, Tsuji T, Matsumoto H, Kato J, Mori T, Okamoto S, Liu M: Factors affecting lower limb muscle strength and cardiopulmonary fitness after allogeneic hematopoietic stem cell transplantation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2019.05; 27 (5): 1793-1800. ( PubMed , DOI )

  32. Tanigawa T, Abe R, Kato J, Hosoe N, Ogata H, Kameyama K, Okamoto S, Mori T: Histological transformation in duodenal-type follicular lymphoma: a case report and review of the literature. Oncotarget. 2019.05; 10 (36): 3424-3429. ( PubMed )

  33. Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Fujisawa S, Onishi Y, Yano S, Onizuka M, Kanda Y, Mizuno I, Taniguchi S, Yamashita T, Inamoto Y, Okamoto S, Atsuta Y: Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey. Bone marrow transplantation. 2019.04; 54 (4): 611-615. ( PubMed , DOI )

  34. Yanada M, Masuko M, Mori J, Aoki J, Mizuno S, Fukuda T, Kakihana K, Ozawa Y, Ota S, Kanamori H, Mori T, Nakamae H, Eto T, Shiratori S, Maeda T, Iwato K, Ichinohe T, Kanda Y, Tanaka J, Atsuta Y, Yano S: Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades. Bone marrow transplantation. 2019.04; 54 (4): 578-586. ( PubMed , DOI )

  35. Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y: Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature. World journal of gastroenterology. 2019.04; 25 (15): 1899-1906. ( PubMed , DOI )

  36. Sakurai M, Kikuchi T, Karigane D, Kasahara H, Matsuki E, Hashida R, Yamane Y, Abe R, Koda Y, Toyama T, Kato J, Shimizu T, Yokoyama Y, Suzuki S, Nakamura T, Okamoto S, Mori T: Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia. International journal of hematology. 2019.03; 109 (3): 292-298. ( PubMed , DOI )

  37. Miyamura K, Yamashita T, Atsuta Y, Ichinohe T, Kato K, Uchida N, Fukuda T, Ohashi K, Ogawa H, Eto T, Inoue M, Takahashi S, Mori T, Kanamori H, Yabe H, Hama A, Okamoto S, Inamoto Y: High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation. Blood advances. 2019.02; 3 (3): 397-405. ( PubMed , DOI )

  38. Nogami Ayako, Okada Keigo, Ishida Shinya, Akiyama Hiroki, Umezawa Yoshihiro, Miura Osamu: Inhibition of the STAT5/Pim Kinase Axis Enhanecs Cytotoxic Effects of Proteasome Inhibitors on FLT3-ITD-Positive Cells by Cooperatively Inhibiting the mTORC1/4EBP1/S6K/Mcl-1 Pathway TRANSLATIONAL ONCOLOGY. 2019.02; 12 (2): 336-349. ( PubMed , DOI )

  39. Keisuke Tanaka, Shigeo Toyota, Megumi Akiyama, Naoki Wakimoto, Yuichi Nakamura, Yuho Najima, Noriko Doki, Kazuhiko Kakihana, Aiko Igarashi, Takeshi Kobayashi, Kazuteru Ohashi, Daisuke Kudo, Atsushi Shinagawa, Hina Takano, Takayuki Fujio, Yasushi Okoshi, Mitsuo Hori, Takashi Kumagai, Tatsuya Saito, Junichi Mukae, Koh Yamamoto, Ikuyo Tsutsumi, Takuya Komeno, Chikashi Yoshida, Masahide Yamamoto, Hiroshi Kojima, : Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial. Acta Haematol.. 2019.02; 141 (2): 111-118. ( PubMed , DOI )

  40. Konuma T, Shimomura Y, Ozawa Y, Ueda Y, Uchida N, Onizuka M, Akiyama M, Mori T, Nakamae H, Ohno Y, Shiratori S, Onishi Y, Kanda Y, Fukuda T, Atsuta Y, Ishiyama K, Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Induction chemotherapy followed by allogeneic HCT versus upfront allogeneic HCT for advanced myelodysplastic syndrome: A propensity score matched analysis. Hematological oncology. 2019.02; 37 (1): 85-95. ( PubMed , DOI )

  41. Konuma T, Kondo T, Kawata T, Iwato K, Sato Y, Mori T, Ohashi K, Nakazawa H, Sugahara H, Ago H, Eto T, Imamura Y, Fukuda T, Kanda Y, Atsuta Y, Yano S, Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Hematopoietic Cell Transplantation for Acute Panmyelosis with Myelofibrosis: A Retrospective Study in Japan. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019.01; 25 (1): e23-e27. ( PubMed , DOI )

  42. Karigane D, Kikuchi T, Sakurai M, Kato J, Yamane Y, Hashida R, Abe R, Hatano M, Hasegawa N, Wakayama M, Shibuya K, Okamoto S, Mori T: Invasive hepatic mucormycosis: A case report and review of the literature. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2019.01; 25 (1): 50-53. ( PubMed , DOI )

  43. Junichi Tsuchiya, Masahide Yamamoto, Hyeyeol Bae, Takumi Oshima, Tomohiro Yoneyama, Osamu Miura, Ukihide Tateishi: Tumor Identification of Less Aggressive or Indolent Lymphoma With Whole-Body 11C-Acetate PET/CT. Clin Nucl Med. 2019.01; ( PubMed , DOI )

  44. Nomoto H, Takami A, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Morishita E: Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy. International journal of molecular sciences. 2019.01; 20 (1): ( PubMed , DOI )

  45. Makoto Nakagawa, Shuhei Fujita, Takuo Katsumoto, Kazutsune Yamagata, Yoko Ogawara, Ayuna Hattori, Yuki Kagiyama, Daisuke Honma, Kazushi Araki, Tatsuya Inoue, Ayako Kato, Koichiro Inaki, Chisa Wada, Yoshimasa Ono, Masahide Yamamoto, Osamu Miura, Yasuharu Nakashima, Issay Kitabayashi: Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma. Cancer Sci.. 2019.01; 110 (1): 194-208. ( PubMed , DOI )

  46. Akiyama Hiroki, Umezawa Yoshihiro, Ishida Shinya, Okada Keigo, Nogami Ayako, Miura Osamu: Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress CANCER LETTERS. 2019; 453 84-94. ( PubMed , DOI )

  1. Arai Ayako, Sakashita Chizuko, Sawada Akihisa, Kimura Hiroshi: Nationwide survey of chemotherapy for CAEBV in Japan CANCER SCIENCE. 2018.12; 109 746.

  2. Yamane M, Ogawa Y, Fukui M, Kamoi M, Uchino M, Saijo-Ban Y, Kozuki N, Mukai S, Mori T, Okamoto S, Tsubota K: Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study. Eye & contact lens. 2018.11; 44 Suppl 2 S215-S220. ( PubMed , DOI )

  3. Sakurai M, Watanuki S, Kato J, Hashida R, Yamane Y, Karigane D, Mitsuhashi T, Murata M, Ueno H, Nakazato T, Okamoto S, Mori T: Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission. Internal medicine (Tokyo, Japan). 2018.11; 57 (22): 3299-3302. ( PubMed , DOI )

  4. Fujita Y, Nakazato T, Ito C, Masuda K, Osada Y, Aisa Y, Mori T: A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment. Annals of hematology. 2018.10; 97 (10): 2009-2010. ( PubMed , DOI )

  5. Okamoto S, Teshima T, Kosugi-Kanaya M, Kahata K, Kawashima N, Kato J, Mori T, Ozawa Y, Miyamura K: Extracorporeal photopheresis with TC-V in Japanese patients with steroid-resistant chronic graft-versus-host disease. International journal of hematology. 2018.09; 108 (3): 298-305. ( PubMed , DOI )

  6. 梅澤 佳央, 渡邉 健, 長尾 俊景, 坂下 千瑞子, 野上 彩子, 川又 紀彦, 三浦 修, 山本 正英: 当院におけるCMLに対する1st lineチロシンキナーゼ阻害薬によるDMR達成の検討(Achieving deep molecular response after first-line TKI therapy for CML) 臨床血液. 2018.09; 59 (9): 1774. ( 医中誌 )

  7. 新井 文子, 坂下 千瑞子, 澤田 明久, 木村 宏: 慢性活動性EBウイルス感染症の本邦における診療実態の全国調査(Nationwide survey of chemotherapy for CAEBV in Japan) 日本癌学会総会記事. 2018.09; 77回 1169. ( 医中誌 )

  8. Takanashi S, Nakazato T, Aisa Y, Ito C, Arakaki H, Osada Y, Hirano M, Mori T: The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders. Annals of hematology. 2018.09; 97 (9): 1611-1618. ( PubMed , DOI )

  9. Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Ichinohe T, Atsuta Y, Takaori-Kondo A: Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018.08; 24 (8): 1596-1601. ( PubMed , DOI )

  10. Inamoto Y, Matsuda T, Tabuchi K, Kurosawa S, Nakasone H, Nishimori H, Yamasaki S, Doki N, Iwato K, Mori T, Takahashi S, Yabe H, Kohno A, Nakamae H, Sakura T, Hashimoto H, Sugita J, Ago H, Fukuda T, Ichinohe T, Atsuta Y, Yamashita T, Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group.: Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation. Blood advances. 2018.08; 2 (15): 1901-1913. ( PubMed , DOI )

  11. Nakazato T, Takanashi S, Hirano M, Ito C, Fujita Y, Osada Y, Aisa Y, Mori T: Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma. Annals of hematology. 2018.08; 97 (8): 1489-1491. ( PubMed , DOI )

  12. Kawamura K, Nakasone H, Kurosawa S, Yoshimura K, Misaki Y, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Wada H, Ishihara Y, Sato M, Terasako-Saito K, Kikuchi M, Kimura SI, Tanihara A, Kako S, Kanamori H, Mori T, Takahashi S, Taniguchi S, Atsuta Y, Kanda Y: Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018.07; 24 (7): 1521-1526. ( PubMed , DOI )

  13. Ogata M, Takano K, Moriuchi Y, Kondo T, Ueki T, Nakano N, Mori T, Uoshima N, Nagafuji K, Yamasaki S, Shibasaki Y, Sakai R, Kato K, Choi I, Jo Y, Eto T, Kako S, Oshima K, Fukuda T: Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018.06; 24 (6): 1264-1273. ( PubMed , DOI )

  14. Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M, Atsuta Y, Nakaseko C: Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018.06; 24 (6): 1180-1186. ( PubMed , DOI )

  15. Motohashi K, Fujisawa S, Doki N, Kobayashi T, Mori T, Usuki K, Tanaka M, Fujiwara S, Kako S, Aoyama Y, Onoda M, Yano S, Gotoh M, Kanamori H, Takahashi S, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT): Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia. Leukemia & lymphoma. 2018.06; 59 (6): 1332-1337. ( PubMed , DOI )

  16. Ishida S, Akiyama H, Umezawa Y, Okada K, Nogami A, Oshikawa G, Nagao T, Miura O: Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2. Oncotarget. 2018.06; 9 (42): 26834-26851. ( PubMed , DOI )

  17. Yamazaki R, Kikuchi T, Kato J, Sakurai M, Koda Y, Hashida R, Yamane Y, Abe R, Hasegawa N, Okamoto S, Mori T: Recurrent bacterial pneumonia due to immunoglobulin G2 subclass deficiency after allogeneic hematopoietic stem cell transplantation: Efficacy of immunoglobulin replacement. Transplant infectious disease : an official journal of the Transplantation Society. 2018.06; 20 (3): e12863. ( PubMed , DOI )

  18. Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R: Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study. Transfusion medicine reviews. 2018.06; ( PubMed , DOI )

  19. Tokuhira M, Saito S, Okuyama A, Suzuki K, Higashi M, Momose S, Shimizu T, Mori T, Anan-Nemoto T, Amano K, Okamoto S, Takeuchi T, Tamaru JI, Kizaki M: Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression. Leukemia & lymphoma. 2018.05; 59 (5): 1143-1152. ( PubMed , DOI )

  20. Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Inoue M, Fukuda T, Ichinohe T, Atsuta Y, Kanda Y: Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018.04; 24 (4): 717-725. ( PubMed , DOI )

  21. Sakurai M, Toyama T, Kikuchi T, Kato J, Shimizu T, Koda Y, Karigane D, Yamane Y, Abe R, Yamazaki R, Nakazato T, Nakahara T, Jinzaki M, Okamoto S, Mori T: Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma. International journal of hematology. 2018.02; 107 (2): 194-200. ( PubMed , DOI )

  22. Yuko Kinowaki, Morito Kurata, Sachiko Ishibashi, Masumi Ikeda, Anna Tatsuzawa, Masahide Yamamoto, Osamu Miura, Masanobu Kitagawa, Kouhei Yamamoto: Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma. Lab. Invest.. 2018.02; ( PubMed , DOI )

  23. Kohashi S, Toyama T, Hashimoto N, Sakurai M, Kato J, Kikuchi T, Koda Y, Sugita K, Hasegawa N, Yarita K, Kamei K, Okamoto S, Mori T: Sinusitis caused by Exserohilum rostratum after cord blood transplantation for myelodysplastic syndrome: A case report and literature review. Transplant infectious disease : an official journal of the Transplantation Society. 2018.02; 20 (1): ( PubMed , DOI )

  24. Ishigaki S, Masaoka T, Kameyama H, Kawaida M, Kameyama K, Mori T, Kanai T: Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma. Internal medicine (Tokyo, Japan). 2018; 57 (22): 3249-3254. ( PubMed , DOI )

  25. Saito S, Suzuki K, Yoshimoto K, Kaneko Y, Yamaoka K, Shimizu T, Mori T, Okamoto S, Kameyama K, Amano K, Tamaru JI, Tokuhira M, Takeuchi T: Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment. Frontiers in immunology. 2018; 9 621. ( PubMed , DOI )

  26. Muta T, Miyamoto T, Kamimura T, Kanda Y, Nohgawa M, Ueda Y, Iwato K, Sasaki O, Mori T, Uchida N, Iida S, Fukuda T, Atsuta Y, Sunami K: Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan. Acta haematologica. 2018; 139 (1): 35-44. ( PubMed , DOI )

  1. Yoshihiro Umezawa, Hiroki Akiyama, Keigo Okada, Shinya Ishida, Ayako Nogami, Gaku Oshikawa, Tetsuya Kurosu, Osamu Miura: Molecular mechanisms for enhancement of stromal cell-derived factor 1-induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1). Journal of Biological Chemistry. 2017.12; 292 (48): 19639-19655.

  2. Keigo Okada, Ayako Nogami, Shinya Ishida, Hiroki Akiyama, Cheng Chen, Yoshihiro Umezawa and Osamu Miura: FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway Oncotarget. 2017.12; 9 8870-8886.

  3. Onishi Y, Mori T, Kako S, Koh H, Uchida N, Kondo T, Kobayashi T, Yabe H, Miyamoto T, Kato K, Suzuki R, Nakao S, Yamazaki H, Adult Aplastic Anemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017.12; 23 (12): 2137-2142. ( PubMed , DOI )

  4. Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y: Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017.10; 23 (10): 1749-1758. ( PubMed , DOI )

  5. Saburi M, Kohashi S, Kato J, Koda Y, Sakurai M, Toyama T, Kikuchi T, Karigane D, Yuda S, Yamane Y, Hashida R, Abe R, Nakazato T, Hirahashi J, Ogata M, Okamoto S, Mori T: Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation. International journal of hematology. 2017.09; 106 (3): 431-435. ( PubMed , DOI )

  6. Murakami K, Kohashi S, Sakurai M, Kato J, Toyama T, Koda Y, Yamane Y, Hashida R, Abe R, Yamazaki R, Kikuchi T, Shimizu T, Suzuki S, Hasegawa N, Okamoto S, Mori T: Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis. International journal of hematology. 2017.09; 106 (3): 436-440. ( PubMed , DOI )

  7. Andreas Herrmann, Christoph Lahtz, Toshikage Nagao, Joo Y Song, Wing C Chan, Heehyoung Lee, Chanyu Yue, Thomas Look, Ronja Mülfarth, Wenzhao Li, Kurt Jenkins, John Williams, Lihua E Budde, Stephen Forman, Larry Kwak, Thomas Blankenstein, Hua Yu: CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity. Cancer Res.. 2017.09; 77 (18): 5118-5128. ( PubMed , DOI )

  8. Masahide Yamamoto, Sayaka Suzuki, Jun-Ichi Mukae, Keisuke Tanaka, Ken Watanabe, Gaku Oshikawa, Tetsuya Fukuda, Naomi Murakami, Osamu Miura: Atypical chronic myeloid leukemia with isochromosome (X)(p10): A case report. Oncol Lett. 2017.09; 14 (3): 3717-3721. ( PubMed , DOI )

  9. He J, Ogawa Y, Mukai S, Saijo-Ban Y, Kamoi M, Uchino M, Yamane M, Ozawa N, Fukui M, Mori T, Okamoto S, Tsubota K: In Vivo Confocal Microscopy Evaluation of Ocular Surface with Graft-Versus-Host Disease-Related Dry Eye Disease. Scientific reports. 2017.09; 7 (1): 10720. ( PubMed , DOI )

  10. Watanabe Daisuke, Yasuda Shunichiro, Kawamata Norihiko, Sakashita Chizuko, Watanabe Ken, Yamamoto Masahide, Fukuda Tetsuya, Miura Osamu: CRISPR/Cas9法を用いたCALR遺伝子のゲノム編集(Genome editing using for CRISPR-Cas9 system in Calreticulin gene) 臨床血液. 2017.09; 58 (9): 1523. ( 医中誌 )

  11. Yamashita Tomoko, Tsutsumi Hiroki, Yoshifuji Kota, Saito Tatsuya, Umezawa Yoshihiro, Nogami Ayako, Watanabe Ken, Nagao Toshikage, Yamamoto Masahide, Sakashita Chizuko, Arai Ayako, Kawamata Norihiko, Miura Osamu, Fukuda Tetsuya: 11番染色体長腕欠失を伴う慢性リンパ性白血病/小リンパ球性リンパ腫(Chronic lymphocytic leukemia/small lymphocytic lymphoma with 11q deletion) 臨床血液. 2017.09; 58 (9): 1573. ( 医中誌 )

  12. Yonese Ichiro, Sakashita Chizuko, Imadome Ken-ichi, Kobayashi Tohru, Sawada Akihisa, Itoh Yoshinori, Fukuhara Noriko, Hirose Asao, Takeda Yusuke, Makita Masanori, Endo Tomoyuki, Kimura Shun-ichi, Ishimura Masataka, Tomita Makoto, Nakamura Keiko, Miura Osamu, Ohga Shouichi, Kimura Hiroshi, Fujiwara Shigeyoshi, Arai Ayako: 慢性活動性EBウイルス感染症の本邦における診療実態の全国調査(Nationwide survey of chemotherapy for CAEBV in Japan) 臨床血液. 2017.09; 58 (9): 1503. ( 医中誌 )

  13. M Matsushita, K Ozawa, T Suzuki, M Nakamura, N Nakano, S Kanchi, D Ichikawa, E Matsuki, M Sakurai, D Karigane, H Kasahara, N Tsukamoto, T Shimizu, T Mori, H Nakajima, S Okamoto, Y Kawakami, Y Hattori: CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients. Blood Cancer Journal. 2017.09; 7 (9): e601. ( PubMed , DOI )

  14. Kondo T, Nagamura-Inoue T, Tojo A, Nagamura F, Uchida N, Nakamae H, Fukuda T, Mori T, Yano S, Kurokawa M, Ueno H, Kanamori H, Hashimoto H, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Ohashi K: Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia. American journal of hematology. 2017.09; 92 (9): 902-908. ( PubMed , DOI )

  15. Namkoong H, Ishii M, Mori T, Sugiura H, Tasaka S, Sakurai M, Koda Y, Kato J, Hasegawa N, Okamoto S, Betsuyaku T: Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation. BMC pulmonary medicine. 2017.09; 17 (1): 123. ( PubMed , DOI )

  16. Arakaki H, Nakazato T, Osada Y, Ito C, Aisa Y, Mori T: Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphoma. Annals of hematology. 2017.07; 96 (7): 1225-1226. ( PubMed , DOI )

  17. Tanaka K, Oshikawa G, Akiyama H, Ishida S, Nagao T, Yamamoto M, Miura O: Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report. Oncology letters. 2017.07; 14 (1): 97-102. ( PubMed , DOI )

  18. Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Kawakita T, Mori T, Hoshino T, Onizuka M, Ozawa Y, Yoshida S, Ueda Y, Mizuno I, Atsuta Y, Mizuta S, Japan Society for Haematopoietic Cell Transplantation.: Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults. British journal of haematology. 2017.07; 178 (1): 106-111. ( PubMed , DOI )

  19. Daiki Karigane, Keiyo Takubo: Metabolic regulation of hematopoietic and leukemic stem/progenitor cells under homeostatic and stress conditions. International Journal of Hematology. 2017.07; 106 (1): 18-26. ( PubMed , DOI )

  20. Kikuchi T, Mori T, Shimizu T, Koda Y, Abe R, Kurihara Y, Funakoshi T, Yamagami J, Sato H, Tsunoda K, Amagai M, Okamoto S: Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus. Annals of hematology. 2017.07; 96 (7): 1221-1222. ( PubMed , DOI )

  21. Uchino K, Mizuno S, Sato-Otsubo A, Nannya Y, Mizutani M, Horio T, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Ogawa S, Takami A: Toll-like receptor genetic variations in bone marrow transplantation. Oncotarget. 2017.07; 8 (28): 45670-45686. ( PubMed , DOI )

  22. Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, Reina Watanabe, Yutaka Shimazu, Yasufumi Masaki, Saburo Tsunoda, Chizuko Hashimoto, Kayoko Murayama, Takahiro Yano, Rumiko Okamoto, Ako Kikuchi, Kazuo Tamura, Kazuya Sato, Kazutaka Sunami, Hirohiko Shibayama, Rishu Takimoto, Rika Ohshima, Hiromichi Takahashi, Yukiyoshi Moriuchi, Tomohiro Kinoshita, Masahide Yamamoto, Ayumi Numata, Hideaki Nakajima, Ikuo Miura, Kengo Takeuchi: The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis. Leuk. Lymphoma. 2017.06; 1-8. ( PubMed , DOI )

  23. Horio T, Mizuno S, Uchino K, Mizutani M, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Takami A: The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation. Transplant immunology. 2017.06; 42 34-39. ( PubMed , DOI )

  24. Masahide Yamamoto, Ken Watanabe, Tetsuya Fukuda, Osamu Miura: Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study. Anticancer Res.. 2017.05; 37 (5): 2655-2662. ( PubMed , DOI )

  25. Yanada M, Yano S, Kanamori H, Gotoh M, Emi N, Watakabe K, Kurokawa M, Nishikawa A, Mori T, Tomita N, Murata M, Hashimoto H, Henzan H, Kanda Y, Sawa M, Kohno A, Atsuta Y, Ichinohe T, Takami A: Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide. Leukemia & lymphoma. 2017.05; 58 (5): 1061-1067. ( PubMed , DOI )

  26. Hashimoto N, Mori T, Hashida R, Sakurai M, Koda Y, Toyama T, Kato J, Okamoto S: False-positive serum (1, 3)-β-D-glucan elevation due to intake of seaweed in a hematopoietic stem cell transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society. 2017.04; 19 (2): ( PubMed , DOI )

  27. Kobayashi R, Mitsui T, Fujita N, Osumi T, Aoki T, Aoki K, Suzuki R, Fukuda T, Miyamoto T, Kato K, Nakamae H, Goto H, Eto T, Inoue M, Mori T, Terui K, Onizuka M, Koh K, Koga Y, Ichinohe T, Sawada A, Atsuta Y, Suzumiya J: Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation. International journal of hematology. 2017.03; 105 (3): 369-376. ( PubMed , DOI )

  28. Mori T, Kanda Y, Takenaka K, Okamoto S, Kato J, Kanda J, Yoshimoto G, Gondo H, Doi S, Inaba M, Kodera Y: Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial. International journal of hematology. 2017.02; 105 (2): 206-212. ( PubMed , DOI )

  29. Konuma T, Miyazaki Y, Uchida N, Ohashi K, Kondo T, Nakamae H, Takahashi S, Mori T, Ozawa Y, Kato C, Iwato K, Fukuda T, Ichinohe T, Atsuta Y, Ishiyama K, Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation.: Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017.01; 23 (1): 75-80. ( PubMed , DOI )

  30. Takenaka K, Shimoda K, Uchida N, Shimomura T, Nagafuji K, Kondo T, Shibayama H, Mori T, Usuki K, Azuma T, Tsutsumi Y, Tanaka J, Dairaku H, Matsuo K, Ozawa K, Kurokawa M, Arai S, Akashi K: Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. International journal of hematology. 2017.01; 105 (1): 59-69. ( PubMed , DOI )

  31. Sasaki T, Akiyama M, Kaneko Y, Mori T, Yasuoka H, Suzuki K, Yamaoka K, Okamoto S, Takeuchi T: Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease. RMD open. 2017; 3 (1): e000432. ( PubMed , DOI )

  1. Koichi Miyamura, Toshihiro Miyamoto, Mitsune Tanimoto, Kazuhito Yamamoto, Shinya Kimura, Tatsuya Kawaguchi, Itaru Matsumura, Tomoko Hata, Hisashi Tsurumi, Shigeki Saito, Masayuki Hino, Seiji Tadokoro, Kuniaki Meguro, Hideo Hyodo, Masahide Yamamoto, Kohmei Kubo, Junichi Tsukada, Midori Kondo, Makoto Aoki, Hikaru Okada, Masamitsu Yanada, Kazuma Ohyashiki, Masafumi Taniwaki: Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy. Leuk. Res.. 2016.12; 51 11-18. ( PubMed , DOI )

  2. Hiroki Akiyama, Hiroshi Takase, Fumito Kubo, Tohru Miki, Masahide Yamamoto, Makoto Tomita, Manabu Mochizuki, Osamu Miura, Ayako Arai: High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma. Cancer Science. 2016.10; 107 (10): 1458-1464. ( PubMed , DOI )

  3. Karigane D, Kobayashi H, Morikawa T, Ootomo Y, Sakai M, Nagamatsu G, Kubota Y, Goda N, Matsumoto M, Nishimura EK, Soga T, Otsu K, Suematsu M, Okamoto S, Suda T, Takubo K: p38α Activates Purine Metabolism to Initiate Hematopoietic Stem/Progenitor Cell Cycling in Response to Stress. Cell stem cell. 2016.08; 19 (2): 192-204. ( PubMed , DOI )

  4. Masahide Yamamoto, Kazuteru Ohashi, Kazuhiko Kakihana, Yuichi Nakamura, Takuya Komeno, Hiroshi Kojima, Satoshi Morita, Hisashi Sakamaki: A multicenter clinical study to determine the feasible initial dose of lenalidomide for maintenance therapy in patients with multiple myeloma following autologous peripheral blood stem-cell transplantation. Mol Clin Oncol. 2016.06; 4 (6): 965-970. ( PubMed , DOI )

  5. Yoshihiro Umezawa, Tetsuya Kurosu, Hiroki Akiyama, Nang Wu, Ayako Nogami, Toshikage Nagao, Osamu Miusa: Down regulation of Chk1 by p53 plays a role in synergistic induction of apoptosis by chemotherapeutics and inhibitors for Jak2 or BCR/ABL in hematopoietic cells. Oncotarget. 2016.06; ( PubMed )

  6. Shunichiro Yasuda, Masahide Yamamoto, Tetsuya Fukuda, Yasufumi Ohtsuka, Osamu Miura: Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with Eculizumab. Intern. Med.. 2016.05; 55 (9): 1171-1175. ( PubMed , DOI )

  7. Arai A, Sakashita C, Hirose C, Imadome K, Yamamoto M, Jinta M, Fujiwara S, Tomita M, Shimizu N, Morio T, and Miura O.: Hematopoietic stem cell transplantation for adults with EBV-positive T- or NK-cell lymphoproliferative disorders: efficacy and predictive markers Bone Marrow Transplantation. 2016.02; ( DOI )

  8. Wakaba Yamaguchi, Naofumi Yui, Toshikage Nagao, Gaku Oshikawa, Mariko Negi, Soichiro Iimori, Tomokazu Okado, Tatemitsu Rai, Shinichi Uchida: Bence-Jones Protein λ-type Multiple Myeloma Patient Withdrawn from Maintenance Hemodialysis after Long-term Bortezomib and Dexamethasone Therapy. Internal Medicine. 2016; 55 (3): 263-268. ( PubMed , DOI )

  1. Emi Uchida, Ken Watanabe, Reina Arai, Masahide Yamamoto, Masayoshi Souri, Tsukasa Osaki, Akitada Ichinose, Osamu Miura, Takatoshi Koyama: Autoimmune Hemorrhaphilia Resulting from Autoantiboy against the A Subunit of Factor XIII. Internal Medicine. 2015.09; 54 (18): 2383-2387.

  2. T Nagao, G Oshikawa, S Ishida, H Akiyama, Y Umezawa, A Nogami, T Kurosu, O Miura: A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival. Blood Cancer J. 2015.05; 5 e314. ( PubMed , DOI )

  3. Hiroshi Kobayashi, Chiharu I Kobayashi, Ayako Nakamura-Ishizu, Daiki Karigane, Hiroshi Haeno, Kimiyo N Yamamoto, Taku Sato, Toshiaki Ohteki, Yoshihiro Hayakawa, Glen N Barber, Mineo Kurokawa, Toshio Suda, Keiyo Takubo: Bacterial c-di-GMP affects hematopoietic stem/progenitors and their niches through STING. Cell Rep. 2015.04; 11 (1): 71-84. ( PubMed , DOI )

  4. Nogami Ayako, Oshikawa Gaku, Okada Keigo, Fukutake Shusaku, Umezawa Yoshihiro, Nagao Toshikage, Kurosu Tetsuya, Miura Osamu: FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia. Oncotarget. 2015.04; 6 (11): 9189-9205. ( PubMed )

  5. Masahide Yamamoto, Keigo Okada, Hiroki Akiyama, Tetsuya Kurosu, Osamu Miura: Evaluation of the efficacy of maintenance therapy for low-to-intermediate-risk acute promyelocytic leukemia in molecular remission: A retrospective single-institution study. Mol Clin Oncol. 2015.03; 3 (2): 449-453. ( PubMed , DOI )

  6. Hiroki Akiyama, Masahide Yamamoto, Chizuko Sakashita, Yoshihiro Umezawa, Tetsuya Kurosu, Naomi Murakami, Osamu Miura: Therapy-related Leukemia with Inv(16)(p13.1q22) and Type D CBFB/MYH11 Developing after Exposure to Irinotecan-containing Chemoradiotherapy. Intern. Med.. 2015; 54 (6): 651-655. ( PubMed , DOI )

  1. Nagao T, Kurosu T, Umezawa Y, Nogami A, Oshikawa G, Tohda S, Yamamoto M, Miura O: Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera. PLoS ONE. 2014; 9 (1): e84746. ( PubMed , DOI )

  1. Nan Wu, Tetsuya Kurosu, Gaku Oshikawa, Toshikage Nagao, Osamu Miura: PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells. Int. J. Oncol.. 2013.02; 42 (2): 419-428. ( PubMed , DOI )

  2. Tetsuya Kurosu, Toshikage Nagao, Nan Wu, Gaku Oshikawa, Osamu Miura: Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis. PLoS ONE. 2013; 8 (11): e79478. ( PubMed , DOI )

  1. Naoto Takahashi, Taiichi Kyo, Yasuhiro Maeda, Takashi Sugihara, Kensuke Usuki, Tatsuya Kawaguchi, Noriko Usui, Shinichiro Okamoto, Yokiko Ohe, Shigeki Ohtake, Kunio Kitamura, Masahide Yamamoto, Hirofumi Teshima, Toshiko Motoji, Toshiharu Tamaki, Kenichi Sawada, Kazuma Ohyashiki: Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia. Haematologica. 2012.06; 97 (6): 903-906. ( PubMed , DOI )

  2. Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, Reina Watanabe, Yutaka Shimazu, Yasufumi Masaki, Saburo Tsunoda, Chizuko Hashimoto, Kayoko Murayama, Takahiro Yano, Rumiko Okamoto, Ako Kikuchi, Kazuo Tamura, Kazuya Sato, Kazutaka Sunami, Hirohiko Shibayama, Rishu Takimoto, Rika Ohshima, Yoshihiro Hatta, Yukiyoshi Moriuchi, Tomohiro Kinoshita, Masahide Yamamoto, Ayumi Numata, Yoshiaki Ishigatsubo, Kengo Takeuchi: Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era. Cancer Sci.. 2012.02; 103 (2): 245-251. ( PubMed , DOI )

  3. Masahide Yamamoto, Kazuteru Ohashi, Yuka Hirashima, Takeshi Kobayashi, Kazuhiko Kakihana, Hideki Akiyama, Hisashi Sakamaki: Poor outcome of myeloablative conditioned allogeneic bone marrow transplantation for myelofibrosis. Intern. Med.. 2012; 51 (10): 1183-1186. ( PubMed )

  1. Gaku Oshikawa, Toshikage Nagao, Nan Wu, Tetsuya Kurosu, Osamu Miura: c-Cbl and Cbl-b ligases mediate 17-allylaminodemethoxygeldanamycin-induced degradation of autophosphorylated Flt3 kinase with internal tandem duplication through the ubiquitin proteasome pathway. J. Biol. Chem.. 2011.09; 286 (35): 30263-30273. ( PubMed , DOI )

  2. Toshikage Nagao, Gaku Oshikawa, Nan Wu, Tetsuya Kurosu, Osamu Miura: DNA damage stress and inhibition of Jak2-V617F cause its degradation and synergistically induce apoptosis through activation of GSK3β. PLoS ONE. 2011; 6 (11): e27397. ( PubMed , DOI )

  1. Yamamoto M, Kakihana K, Ohashi K, Yamaguchi T, Tadokoro K, Akiyama H, Sakamaki H: Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR. Int J Hematol. 2009.05; 89 (4): 482-488. ( PubMed , DOI )

  1. Tetsuya Kurosu, Kana Tsuji, Manabu Ohki, Tohru Miki, Masahide Yamamoto, Kazuhiko Kakihana, Takatoshi Koyama, Shuichi Taniguchi, Osamu Miura: A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25). Int. J. Hematol.. 2008.09; 88 (2): 192-196. ( PubMed , DOI )

  1. Takatoshi Koyama, Toshikage Nagao, Hidefumi Tsunozaki, Morio Arai, Osamu Miura: Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII. Pathophysiol. Haemost. Thromb.. 2006; 35 (5): 405-407. ( PubMed , DOI )

  1. Kazuhiko Kakihana, Masahide Yamamoto, Mitsuko Iiyama, Osamu Miura: Calmodulin physically interacts with the erythropoietin receptor and enhances Jak2-mediated signaling. Biochem. Biophys. Res. Commun.. 2005.09; 335 (2): 424-431. ( PubMed , DOI )

  2. Yamamoto M, Kakihana K, Kurosu T, Murakami N, Miura O: Clonal evolution with inv(11)(p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia. Cancer Genet Cytogenet. 2005.03; 157 (2): 104-108. ( PubMed , DOI )

  1. Yamamoto M, Kurosu T, Kakihana K, Mizuchi D, Miura O: The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinase. Biochem Biophys Res Commun. 2004.07; 319 (4): 1272-1275. ( PubMed , DOI )

  1. 耕納 飛鳥, 田中 圭祐, 島田 智仁, 坂東 夏菜, 高畑 篤, 厚井 聡志, 山 本 正英, 森 毅彦, 豊田 茂: Alectinib により完全奏効達成後に同種造血幹細胞移植を施行した難治性ALK 陽性未分化 大細胞リンパ腫 臨床血液. 2024.03;

  2. Kono A, Tanaka K, Shimada T, Bando K, Takahata A, Koi S, Yamamoto M, Mori T, Toyota S: [Successful bridging therapy with alectinib prior to allogeneic stem cell transplantation for refractory ALK-positive anaplastic large cell lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2024; 65 (3): 158-163. ( PubMed , DOI )

  1. Tanaka Keisuke, Ichikawa Ayako, Umezawa Natsuka, Yamamoto Kouhei, Yoshifuji Kota, Okada Keigo, Nogami Ayako, Umezawa Yoshihiro, Nagao Toshikage, Sakashita Chizuko, Mori Takehiko, Tohda Shuji, Koike Ryuji, Yasuda Shinsuke, Yamamoto Masahide: Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis CANCER SCIENCE. 2023.06; ( PubMed , DOI )

  2. 森　毅彦: 好中球減少症 Medical Practice. 2023.02; 40 (2): 329.

  3. Tomoyasu Jo, Tomoko Henzan, Daisuke Tomizawa, Satoru Yoshihara, Kaoru Kahata, Minami Yamada-Fujiwara, Yoshiki Okuyama, Norio Shiba, Keiko Fujii, Yoshihiro Umezawa, Rie Yamazaki, Wataru Takeda, Ryo Hanajiri, Kentaro Fukushima, Naoya Mimura, Junko Ikemoto, Keita Iwaki, Noboru Yonetani, Shin-Ichiro Fujiwara, Masaki Ri, Tokiko Nagamura-Inoue, Ryuji Tanosaki, Yasuyuki Arai: Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy. Rinsho Ketsueki. 2023; 64 (5): 331-337. ( PubMed , DOI )

  4. Koi S, Nogami A, Fujiwara H, Bando K, Saito M, Osada Y, Tanaka K, Sakashita C, Yoshifuji K, Okada K, Umezawa Y, Nagao T, Yamamoto M, Mori T: Acute promyelocytic leukemia with asymptomatic cerebral hemorrhage. Rinsho ketsueki. 2023; 64 (11): 1426-1430. ( PubMed , DOI )

  5. Hirate T, Kitazawa H, Sakaguchi H, Akita N, Hasegawa C, Yamamoto K, Kutsuna S, Mikita K, Mori T, Hama A, Yoshida N: Cerebral toxoplasmosis developed after unrelated bone marrow transplantation for acute myeloid leukemia. Rinsho ketsueki. 2023; 64 (10): 1275-1279. ( PubMed , DOI )

  1. 斉藤　真貴子, 梅澤　佳央: AMLに対するIDH1/2阻害薬の臨床効果 血液内科. 2022.12; 85 (6): 803-807.

  2. 岡田 隆平, 長尾 俊景, 金井 光, 朝蔭 孝宏: 症例をどうみるか　シスプラチン+5-FU+セツキシマブ療法開始3年後にt-MDSを発症した1例 JOHNS. 2022.11; 38 (11): 1517-1521. ( 医中誌 )

  3. 長尾 俊景, 坂東 夏菜, 井浦 亜有子, 角田 龍太, 加納 嘉人, 池田 貞勝, 野上 彩子, 田中 陽典, 桐村 進, 森 毅彦: 多発性骨髄腫と類似の病像を呈した悪性パラガングリオーマ 臨床血液. 2022.10; 63 (10): 1373-1378. ( 医中誌 )

  4. 森　文子，黒澤彩子，山口拓洋、森　毅彦，金森平和、大西　康、恵美宣彦、藤澤　信、河野彰夫，中世古知昭，齋藤文護，近藤忠一，梅本由香里，名和由一郎，加藤俊一，橋本明子，福田隆浩、矢ヶ崎　香: 急性白血病患者が治療後に経験する生活上の困難感とその対処に関する検討―健康関連 QOL の側面に基づく質的分析― 日本造血・免疫細胞療法学会雑誌. 2022.06; 11 (3): 1-10.

  5. 藤原煕基、森毅彦: 悪性リンパ腫の最新の治療ー抗体医薬 Medical Practice. 2022.04; 39 (4): 585-588.

  6. 坂東夏菜、森毅彦: 慢性リンパ性白血病に対する造血幹細胞移植の位置づけ 血液内科. 2022.02; 84 (2): 182-185.

  7. 木村萌、西山優、上田浩樹、北條亜樹子、有松朋之、久保木麻衣、髙畑篤、斎藤真貴子、坂下千瑞子、岡田啓五、梅澤佳央、長尾俊景、山本正英、東田修二、田邉稔、森毅彦 、野上彩子: Ravulizumab投与下の発作性夜間ヘモグロビン尿症の腹腔鏡下胆嚢摘出術の周術期管理 臨床血液. 2022; 63 (4): 260-264. ( PubMed , DOI )

  1. 坂下千瑞子,新井文子: 反復する伝染性単核球症様の症状は慢性活動性EBV感染症を考える 内科. 2021.09; 128 (3): 445-447. ( DOI , 医中誌 )

  2. 山﨑 理絵, 甲田 祐也, 安部 涼平, 櫻井 政寿, 菊池 拓, 加藤 淳, 大内 健嗣, 三上 修治, 森 毅彦: 自家造血幹細胞移植後の皮膚再発病変が自然寛解したALK陽性未分化大細胞型リンパ腫 臨床血液. 2021.01; 62 (1): 25-29. ( PubMed , DOI )

  3. 菊池 拓, 水野 洸太, 森 毅彦: 濾胞性リンパ腫の化学療法後に発症しST合剤による治療後に早期再燃したpneumocystis肺炎 臨床血液. 2021.01; 62 (1): 42-46. ( PubMed , DOI )

  1. 田畑 真梨子, 佐藤 悠佑, 木暮 泰寛, Mcclure Marni B., 熊手 祐二, 斎藤 優樹, 新垣 清登, 吉藤 康太, 古屋 淳史, 白石 友一, 久米 春喜, 片岡 圭亮: 遺伝性淡明細胞型腎細胞癌における腫瘍内または腫瘍間の遺伝的、免疫的不均一性 日本泌尿器科学会総会. 2020.12; 108回 804. ( 医中誌 )

  2. 熊谷 拓磨, 土岐 典子, 小林 武, 山田 倫, 比島 恒和, 安達 弘人, 小沼 亮介, 藤田 昌宏, 和田 敦司, 岸田 侑也, 小西 達矢, 永田 啓人, 山田 裕太, 海渡 智史, 吉藤 康太, 迎 純一, 秋山 めぐみ, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 垣花 和彦, 坂巻 壽, 大橋 一輝: 同種骨髄移植後空胞性脊髄症を発症した急性リンパ性白血病 臨床血液. 2020.11; 61 (11): 1625-1627. ( 医中誌 )

  3. 野上　彩子、山本　正英、山本　浩平、伊藤　雅文、梅澤　佳央、東田　修二、三浦　修 、福田　哲也: 汎血球減少の長期経過後に明らかとなった辺縁帯リンパ腫様の骨髄原発リンパ腫 臨床血液. 2020.10; 61 (10): 1469-1475. ( PubMed , DOI )

  4. 厚井 聡志, 新井 康祐, 野上 彩子, 當間 勇人, 山本 正英, 三浦 修, 長尾 俊景: 維持血液透析中の亜鉛投与で生じた銅欠乏による造血障害 臨床血液. 2020.10; 61 (10): 1487-1491. ( PubMed , DOI )

  5. 吉藤 康太, 片岡 圭亮: 【臨床血液学-診断と治療におけるパラダイムシフト2020(リンパ系疾患)-】悪性リンパ腫のゲノム異常 臨床血液. 2020.05; 61 (5): 503-509. ( 医中誌 )

  6. 内田 智之, 土岐 典子, 岸田 侑也, 永田 啓人, 山田 裕太, 小西 達矢, 海渡 智史, 黒澤 修兵, 吉藤 康太, 白根 脩一, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 武藤 秀治, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝: Ph陽性ALLに対する同種造血幹細胞移植後のTKIによる維持療法 臨床血液. 2020.01; 61 (1): 11-19. ( 医中誌 )

  7. Nakayama H, Kato J, Kikuchi T, Okayama M, Kamiya T, Mizuno K, Shimizu T, Okamoto S, Mori T: [Systemic varicella-zoster infection during ixazomib-containing multiagent chemotherapy for multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2020; 61 (8): 870-873. ( PubMed , DOI )

  8. Mizuno K, Yamazaki R, Uemura T, Koda Y, Kikuchi T, Mori T: [Two serial events of delayed hemolytic transfusion reactions due to different primary immune response-induced irregular antibodies]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2020; 61 (10): 1482-1486. ( PubMed , DOI )

  9. Abe R, Kato J, Hashida R, Yamane Y, Koda Y, Kikuchi T, Shimizu T, Kohno T, Kawano F, Imadome KI, Inoue M, Sasaki A, Kameyama K, Mori T: [Chronic active Epstein-Barr virus infection with multiple vascular lesions successfully treated by cord blood transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2020; 61 (10): 1502-1507. ( PubMed , DOI )

  10. Abe R, Yamane Y, Shiroshita K, Koda Y, Sakurai M, Kato J, Mori T: [Efficacy of photocatalytic air purifiers in reducing dimethyl sulfide malodor following cryopreserved peripheral blood stem cell infusion]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2020; 61 (8): 885-887. ( PubMed , DOI )

  1. 岸田 侑也, 小林 武, 藤田 昌宏, 熊谷 拓磨, 吉藤 康太, 秋山 めぐみ, 稲木 恭子, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 土岐 典子, 垣花 和彦, 坂巻 壽, 大橋 一輝: 多種類の栄養欠乏症により汎血球減少と皮膚色素斑を生じ血液悪性疾患との鑑別を要した1例 臨床血液. 2019.10; 60 (10): 1503. ( 医中誌 )

  2. 坂下 千瑞子: 場の持つちから、人の持つちから-自分らしく安心して病と共に過ごすために-　患者力を高めるピアサポートの現場より 死の臨床. 2019.06; 42 (1): 118-119. ( 医中誌 )

  3. 鈴木 さやか, 渡邊 怜奈, 和田 良樹, 本村 鷹多朗, 園川 佐絵子, 岡田 啓五, 熊谷 隆志: 著明な形質細胞増多で発症した血管免疫芽球性T細胞リンパ腫 日本内科学会雑誌. 2019.05; 108 (5): 992-997. ( 医中誌 )

  4. 藤原 煕基, 野口 侑真, 長尾 俊景, 高橋 幸伸, 新井 康祐, 濱村 貴史, 山下 知子, 野上 彩子, 梅澤 佳央, 渡邉 健, 坂下 千瑞子, 山本 正英, 新井 文子, 川又 紀彦, 東田 修二, 三浦 修: シタラビン・プレドニゾロン併用療法が奏効した多臓器型Langerhans細胞組織球症 臨床血液. 2019.05; 60 (5): 523. ( 医中誌 )

  5. 渡部 良平, 安田 峻一郎, 青山 慧, 大蔵 美幸, 渡邉 大介, 秋山 弘樹, 山下 知子, 新井 康祐, 濱村 貴史, 野口 侑真, 梅澤 佳央, 渡邉 健, 長尾 俊景, 山本 正英, 三浦 修, 山内 高弘, 川又 紀彦: 国際標準法(IS)によるBCR-ABL mRNA測定が不能だった慢性骨髄性白血病の分子生物学的解析 臨床血液. 2019.05; 60 (5): 524. ( 医中誌 )

  6. 渡邉 健, 吉藤 康太, 齋藤 達也, 山下 知子, 野上 彩子, 坂下 千瑞子, 福田 哲也, 新井 文子, 東田 修二, 川又 紀彦, 三浦 修, 山本 正英: 腫瘍随伴性天疱瘡と閉塞性細気管支炎を合併した濾胞性リンパ腫 臨床血液. 2019.01; 60 (1): 7-11. ( 医中誌 )

  7. Motomura Y, Arai K, Yoshifuji K, Sonokawa S, Suzuki S, Kumagai T: [Chronic myeloid leukemia harboring T315I and F317L mutations successfully treated with interferon-α and ponatinib]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2019; 60 (1): 33-38. ( PubMed , DOI )

  8. Watanabe K, Yoshifuji K, Saito T, Yamashita T, Nogami A, Sakashita C, Fukuda T, Arai A, Tohda S, Kawamata N, Miura O, Yamamoto M: [Follicular lymphoma accompanied by paraneoplastic pemphigus and bronchiolitis obliterans: a case report]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2019; 60 (1): 7-11. ( PubMed , DOI )

  9. Mori T, Kikuchi T, Sakurai M, Kato J, Koda Y, Abe R, Sumiya C, Yamazaki R, Sugita K, Hasegawa N, Okamoto S: [Bacteriocidal effects of introducing copper products on highly touched areas in hematology ward]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2019; 60 (1): 3-6. ( PubMed , DOI )

  10. Umezawa Y, Kawamata N: Novel therapies for acute myeloid leukemia based on genomic aberrations. Rinsho Ketsueki. 2019; 60 (6): 594-599. ( PubMed , DOI )

  11. Mori T: [Management of cytomegalovirus infection after hematopoietic stem cell transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2019; 60 (9): 1337-1340. ( PubMed , DOI )

  1. 山下 知子, 梅澤　佳央, 渡邉　健, 福田　哲也, 川又　紀彦, 三浦　修, 山本　正英 : 中枢神経リンパ腫に対するブスルファンを含む前処置を用いた自家造血幹細胞移植の検討 日本造血細胞移植学会誌. 2018.10; 7 (4): 145-151. ( DOI )

  2. 澤田 めぐみ, 新井 文子, 坂下 千瑞子, 出江 洋介, 瀧 玲子, 笠井 靖代, 田澤 立之, 岩田 敏, 小川原 純子: 小学生を対象としたこども医学教室の意義　保護者アンケートの質的分析 医学教育. 2018.07; 49 (Suppl.): 155. ( 医中誌 )

  3. 池田 朱里, 堤 大樹, 渡邉 健, 青山 慧, 齊藤 達也, 長尾 俊景, 坂下 千瑞子, 山本 正英, 福田 哲也, 東田 修二, 新井 文子, 川又 紀彦, 三浦 修: 二次性骨髄線維症による門脈圧亢進症性消化管出血に対しルキソリチニブが著効した1例 臨床血液. 2018.05; 59 (5): 626-627. ( 医中誌 )

  4. Watanuki S, Kikuchi T, Toyama T, Abe R, Nakayama H, Karigane D, Shimizu T, Kikuchi J, Matsumoto K, Yasuoka H, Kataoka M, Okamoto S, Mori T: [Mixed connective tissue disease with pulmonary hypertension developing in a chronic myeloid leukemia patient on dasatinib treatment]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2018; 59 (2): 174-177. ( PubMed , DOI )

  5. Nakayama H, Kikuchi T, Abe R, Tozawa K, Watanuki S, Shimizu T, Mitsuhashi T, Murata M, Okamoto S, Mori T: [Evans syndrome complicated with multicentric Castleman disease successfully treated with tocilizumab]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2018; 59 (8): 997-1001. ( PubMed , DOI )

  1. 渡邉 健, 吉藤 康太, 齋藤 達也, 山下 知子, 野上 彩子, 山本 正英, 坂下 千瑞子, 福田 哲也, 新井 文子, 東田 修二, 川又 紀彦, 三浦 修: 腫瘍随伴性天疱瘡と閉塞性細気管支炎を合併した濾胞性リンパ腫の1例 臨床血液. 2017.11; 58 (11): 2274. ( 医中誌 )

  2. Hashida R, Kohashi S, Kato J, Kikuchi T, Sakurai M, Toyama T, Koda Y, Yamane Y, Abe R, Shimizu T, Yamazaki R, Mitsuhashi T, Murata M, Okamoto S, Mori T: Single-institutional retrospective analysis of Japanese patients with chronic lymphocytic leukemia. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2017; 58 (4): 282-286. ( PubMed , DOI )

  3. Murakami K, Mori T, Kato J, Shimizu T, Kohashi S, Sakurai M, Sugita K, Hasegawa N, Murata M, Okamoto S: Bacteremia due to Capnocytophaga species during chemotherapy-induced neutropenia in patients with hematological malignancies. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2017; 58 (3): 210-215. ( PubMed , DOI )

  4. Yamane Y, Koda Y, Kohashi S, Kato J, Hashida R, Sakurai M, Toyama T, Kikuchi T, Okayama M, Kasahara H, Karigane D, Shimizu T, Okamoto S, Mori T: Allogeneic hematopoietic stem cell transplantation following treatment with brentuximab vedotin for refractory Hodgkin lymphoma. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2017; 58 (7): 755-759. ( PubMed , DOI )

  1. 秋山　めぐみ,吉藤　康太,福田　哲也,東田　修二,三木　徹,三浦　修,山本　正英: 自己免疫性溶血性貧血に対するprednisolone治療中に発症した皮膚症状を伴わない劇症型内臓播種性VZV感染症 臨床血液. 2016.04; 57 (4): 467-471. ( PubMed , DOI )

  2. 内田　慧美, 渡邉　健, 押川　学, 坂下　千瑞子, 黒須　哲也, 福田　哲也, 新井　文子, 村上　直巳, 三浦　修, 山本　正英: MLL-AF9遺伝子転座を伴う難治性の乳房原発骨髄肉腫 臨床血液. 2016.01; 57 (1):

  1. 長尾俊景、三浦 修: Jak2-V617F と Lyn からの GSK3 および mTOR 経路を介した生存と増殖のシグナル 伝達機構の新規樹立 Jak2-V617F 陽性 AML 細胞株 PVTL-1 における解析 BioMedサーカス. 2014.02;

  1. Masahide Yamamoto, Hanae Kumekawa, Koji Sasaki, Yutaka Murata, Manabu Ohki, Tetsuya Kurosu, Tetsuya Fukuda, Ayako Arai, Naomi Murakami, Osamu Miura: [Marked reactive plasmacytosis accompanied by drug eruption in a patient with aplastic anemia]. Rinsho Ketsueki. 2012.05; 53 (5): 526-530. ( PubMed )

  1. 鈴木隆之、新井文子、小山高敏、押川学、山本正英、水地大輔、黒須哲也、東田修二、村上直巳、三木徹、三浦修: 後天性血友病Aの急性出血に対する治療後に発症した虚血性大腸炎. 臨床血液. 2006.04; 47 (4): 310-314. ( PubMed )

  1. Toshikage Nagao, Koh Yamamoto, Asako Kitano, Minako Jinta, Takatoshi Koyama, Osamu Miura: [Acquired hemophilia developing after treatment of idiopathic interstitial pneumonia]. Rinsho Ketsueki. 2005.10; 46 (10): 1156-1159. ( PubMed )

  2. Asako Kitano, Koh Yamamoto, Toshikage Nagao, Minako Yoshida, Tetsuya Kurosu, Ayako Arai, Tohru Miki, Naomi Murakami, Osamu Miura: [Successful treatment with drainage of hematoma and chemotherapy in a case of Burkitt leukemia presenting with subdural hematoma]. Rinsho Ketsueki. 2005.04; 46 (4): 278-280. ( PubMed )

  1. Koh Yamamoto, Minako Yoshida, Masahide Yamamoto, Manabu Ohki, Tohru Miki, Takao Horiuchi, Masayuki Kurosaki, Mamoru Watanabe, Osamu Miura: [An abdominal follicular dendritic cell tumor in Castleman's disease]. Rinsho Ketsueki. 2004.09; 45 (9): 1033-1038. ( PubMed )

このページの先頭へ▲